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Abstract 
The cellular response to radiation is governed by a complex signaling network that is 
regulated by the ubiquitin-proteasome system in multiple ways. The AAA-type ATPase 
p97 (also known as VCP or Cdc48) has emerged as a central element of the ubiquitin-
proteasome system as it facilitates the degradation of critical substrate proteins by the 
proteasome. As such, it is involved in replication stress and DNA damage responses, 
and is currently explored as a cancer drug target in clinical trials. However, its function 
is still poorly understood. p97 cooperates with protein cofactors, three of which have 
been linked to the radiation response: the heterodimeric Ufd1-Npl4 ubiquitin adapter, 
DVC1 and UBXD7 that acts as an adapter to cullin-RING ubiquitin ligases (CRLs). 
This work provides insight into three different aspects of the role of p97 and its 
cofactors in the response to replication stress and DNA damage in human cells. First, 
we investigated the relevance of p97 for DNA damage checkpoints. Second, we 
examined the significance of p97 and its cofactors for survival of human cancer cells 
after replication stress. Third, we explored the role of a novel p97 cofactor, UBXD7 that 
was linked to DNA-related functions of p97. Analyses of the G1/S and intra S 
checkpoints showed that p97Ufd1-Npl4 may only play a minor role in these checkpoints. 
However, DVC1 is crucial for the intra S checkpoint. Importantly, work from this study 
contributed to demonstrating that the p97Ufd1-Npl4 complex ensures robustness of the 
G2/M checkpoint by facilitating the degradation of the phosphatase CDC25A 
(published in Riemer et al, 2014). This study confirmed the relevant target protein of 
p97, CDC25A, in the checkpoint and contributed to the identification of the cofactors 
involved in CDC25A degradation, including the novel p97 cofactor UBXD7. Moreover, 
we could demonstrate that in mammalian cells, unrepaired DNA damage from 
interphase manifests in mitotic segregation errors in cells depleted of p97Ufd1-Npl4 and 
that the lack of either of these components decreased cell survival after replication 
stress. Furthermore, p97 inhibition with the inhibitor NMS-873 showed a synergistic 
effect with the genotoxic chemotherapeutic agent doxorubicin. Additionally, NMS-873 
was able to delay the degradation of CDC25A in the DNA damage response. Finally, 
by investigating the significance of UBXD7 for diverse p97 substrate proteins, we found 
that UBXD7 is not generally involved in CRL- and p97-dependent degradation both in 
the nucleus and the cytoplasm. Moreover, a detailed structure-function analysis 
revealed that binding to CRLs and p97 is essential for UBXD7 function. 
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Zusammenfassung 
Die zelluläre Strahlenantwort wird von einem komplexen Signalnetzwerk gesteuert, das 
auf vielfältige Weise vom Ubiquitin-Proteasom-System reguliert wird. Ein zentrales 
Element des Ubiquitin-Proteasom-Systems stellt die AAA-ATPase p97 (auch bekannt 
als VCP oder Cdc48) dar, welche die Degradation von kritischen Substratproteinen 
durch das Proteasom unterstützt. p97 ist involviert in die zelluläre Reaktion auf 
Replikationsstress und DNA-Schäden und wird gegenwärtig als Wirkstoffziel für 
Krebsmedikamente in klinischen Studien erforscht. Dennoch ist seine Funktion noch 
wenig verstanden. p97 kooperiert mit Protein-Kofaktoren, von denen drei mit der 
zellulären Strahlenantwort in Verbindung gebracht wurden: der heterodimere Ufd1-
Npl4-Ubiquitin-Adapter, DVC1 und UBXD7, welches als Adapter für Cullin-RING-
Ubiquitin-Ligasen (CRLs) fungiert. 
Diese Arbeit bietet Einblick in drei verschiedene Aspekte der Rolle von p97 und seinen 
Kofaktoren in der Reaktion auf Replikationsstress und DNA-Schäden in menschlichen 
Zellen. Zunächst wurde die Relevanz von p97 für die Zellzyklus-Kontrollpunkte 
untersucht. Danach wurde die Bedeutung von p97 und seinen Kofaktoren für das 
Überleben humaner Krebszellen nach Replikationsstress überprüft. Schließlich wurde 
der neue p97-Kofaktor UBXD7, der mit Funktionen in Bezug auf DNA in Verbindung 
gebracht wurde, untersucht. Analysen des G1/S- und des intra-S-Kontrollpunkts haben 
gezeigt, dass p97Ufd1-Npl4 möglicherweise eine untergeordnete Rolle in diesen 
Kontrollpunkten spielt. DVC1 jedoch ist entscheidend für den intra-S-Kontrollpunkt. 
Arbeiten dieser Studie haben zu dem Nachweis beigetragen, dass der p97Ufd1-Npl4-
Komplex die Robustheit des G2/M-Kontrollpunkts gewährleistet, indem er die 
Degradation der Phosphatase CDC25A unterstützt (publiziert in Riemer et al, 2014). 
Diese Arbeit bestätigt CDC25A als das relevante Zielprotein von p97 im Kontrollpunkt 
und trug zur Identifikation der an der CDC25A-Degradation beteiligten Kofaktoren bei, 
einschließlich des neuen p97-Kofaktors UBXD7. Darüber hinaus konnte gezeigt 
werden, dass sich in Säugerzellen mit herunterreguliertem p97Ufd1-Npl4 unreparierte 
DNA-Schäden aus der Interphase in der Mitose in Segregationsdefekten manifestieren. 
Zudem minderte der Mangel an einer dieser Komponenten das Überleben der Zellen 
nach Replikationsstress. Darüber hinaus wies p97-Inhibition mit dem Inhibitor NMS-
873 einen synergistischen Effekt mit dem genotoxischen Chemotherapeutikum 
Doxorubicin auf. Zusätzlich verzögerte NMS-873 die Degradation von CDC25A in der 
DNA-Schadenantwort. Durch die Erforschung der Relevanz von UBXD7 für diverse 
p97-Substratproteine konnte schließlich gezeigt werden, dass UBXD7 nicht generell in 
CRL- und p97-abhängigem Abbau im Nukleus und Zytoplasma involviert ist. Eine 
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detaillierte Struktur-Funktionsanalyse hat ergeben, dass die Bindung an CRLs und p97 
für die Funktion von UBXD7 essentiell ist. 
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1 Introduction 
1.1 The mammalian cell cycle 
The cell cycle or cell division cycle is defined as the sequence of events in a cell that 
leads to faithful transmission of the whole genetic material to two daughter cells. In 
mammalian cells, the cell cycle is divided into G1, S, G2 and M phase. During G1, the 
cell grows and prepares for DNA duplication, which takes place in S phase. In G2, the 
cell accumulates nutrients and arranges for cell division which finally happens during M 
phase. Timely and accurate cell cycle progression is controlled by cyclins and cyclin-
dependent kinases (CDKs), which belong to the family of serine/threonine kinases. The 
catalytic activity of CDKs is triggered by complex formation with a cyclin. Upon cyclin 
binding, CDKs phosphorylate and thereby activate or inactivate target proteins. This 
orchestrates coordinated entry into the next cell cycle phase. Different cyclin-CDK 
combinations determine substrate targeting. While CDKs are constitutively expressed 
in cells, cyclins are synthesized and degraded at specific cell cycle stages to restrict 
the activity of the different CDK-cyclin complexes to their specific cell cycle phase 
(Nurse, 2000). Progression through S phase is driven by CDK2-cyclin E and CDK2-
cyclin A. In contrast, initiation and progression through mitosis is governed by CDK1-
cyclin A and CDK1-cyclin B. Besides cyclin degradation, CDK activity is regulated by 
reversible inactivation via phosphorylation of two residues within the ATP-binding loop, 
T14 and Y15, through the WEE1 and myelin transcription factor 1 (MYT1) kinases 
(Malumbres & Barbacid, 2005). When progression into the next phase of the cell cycle 
requires CDK activity, cell division cycle (CDC) 25 dual-specific phosphatases remove 
these inhibitory phosphates, thereby activating the CDK-cyclin complex and promoting 
cell cycle progression (Donzelli & Draetta, 2003). 
 
1.1.1 DNA replication 
DNA replication describes the process in which two identical replicas are produced 
from one original DNA molecule. For maintenance of genome integrity, it is 
indispensable that the genome is replicated exactly once per cell cycle. The elucidation 
of the DNA double helix structure by Watson and Crick in 1953 led to the discovery of 
semi-conservative replication, meaning that each strand of the double helix serves as a 
template for synthesis of a new strand (Watson & Crick, 1953; Meselson & Stahl, 
1958). Since this finding, many molecular details of DNA synthesis have been 
revealed. Replication proceeds in three steps: initiation, elongation and termination. 
The initiation takes place at specific locations in the genome, termed origins of 
replication, where initiator proteins (DeLaBarre et al, 2006) are recruited to already 
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during G1 phase (Yardimci & Walter, 2014). In eukaryotes, replication initiation starts 
with binding of the origin recognition complex (ORC) to DNA. ORC is a hetero-hexamer 
consisting of the subunits Orc1 to Orc6. ORC in turn recruits the cell division cycle 
protein 6 (Cdc6) and the chromatin licensing and DNA replication factor 1 (CDT1), 
which are required to load the minichromosome maintenance (MCM) complex onto 
chromatin. The MCM complex is a hetero-hexameric ring that encircles DNA and is 
built of the six homologous AAA (ATPases associated with diverse cellular activities) 
enzymes Mcm2 to Mcm7. Altogether, this complex of ORC, Cdc6, CDT1 and MCM 
complex is called the pre-replicative complex (pre-RC) and the assembly of the pre-RC 
is defined as replication licensing (Bell & Dutta, 2002; Sclafani & Holzen, 2007). 
Hundreds of thousands of Mcm2-7 complexes are loaded onto DNA in the form of 
head-to-head double hexamers, but only 30-50 thousand of these are activated per 
human cell during DNA replication, while the rest stays dormant and is only activated in 
the case of replication stress (McIntosh & Blow, 2012). Activation of the MCM complex 
takes place when cells enter S phase and requires phosphorylation via Dbf4-
dependent kinase (DDK) and S phase CDKs (Boos et al, 2012; Tanaka & Araki, 2013). 
This phosphorylation step entails recruitment of two further factors, CDC45 and Go-
Ichi-Ni-San (GINS, representative for the subunits SLD-5, PSF-1, PSF-2, and PSF-3), 
to the MCM complex and hence formation of the CMG (CDC45, Mcm2-7, GINS) 
helicase complex (Ilves et al, 2010). The two active CMG helicase complexes formed 
from an inactive Mcm2-7 double hexamer establish bi-directional replication forks by 
unzipping DNA and moving away from each other (Yardimci et al, 2010). The 
replication machinery, also termed replisome, is built around the CMG helicase which 
associates stably with DNA replication forks until the termination of DNA synthesis 
(Boos et al, 2012). Overall, the replisome consists of about 150 proteins including DNA 
polymerases α, δ and ε, the sliding clamp proliferating cell nuclear antigen (PCNA), 
which enhances the processivity of DNA polymerases, and replication protein A (RPA), 
which prevents re-annealing of single-stranded DNA. During the elongation step, a 
primase adds RNA primers to template strands, one to the leading strand and several 
to the lagging strand. Starting from the primers, a high-processivity DNA polymerase 
extends the strand in 5’ to 3’ direction. When two converging replication forks from 
neighboring origins encounter, DNA synthesis is terminated locally which leads to a 
rapid disassembly of the replisomes. MCM complex removal from chromatin is 
facilitated by the mini-chromosome maintenance complex-binding protein (MCM-BP) 
and its interacting partner ubiquitin-specific-processing protease 7, or short USP7 
(Nishiyama et al, 2011; Jagannathan et al, 2013). Finally, topoisomerase II resolves the 
daughter DNA molecules (Fachinetti et al, 2010). 
Introduction 
18 
 
1.1.2 Mitosis 
Mitosis is the cell cycle phase in which replicated chromatids are equally distributed 
into two daughter cells. The process needs to be highly regulated to prevent 
segregation errors that result in chromosomal instability and hence lead to cancer 
(Kops et al, 2005). At the beginning of mitosis, the chromosomes condense in 
prophase and the formation of the mitotic spindle is initiated (Fig. 1.1). The nuclear 
envelope, which separates the nucleus from cytoplasm, breaks down during 
prometaphase. Protruding microtubules from opposite poles of the mitotic spindle 
attach stochastically to kinetochores at the centromeres of the chromosomes in a 
bipolar manner aligning the chromosomes at the center of the cell at the metaphase 
plate. Erroneous microtubule-kinetochore attachments have to be corrected to ensure 
faithful chromosome segregation (Lampson et al, 2004). In anaphase, the microtubules 
contract in order to pull the sister chromatids of each chromosome to opposing sites of 
the cell. During telophase, a new nuclear envelope forms around the segregated 
chromatin, before the cell actually divides in cytokinesis. 
 
 
Figure 1.1: The mitotic phases. At the beginning of mitosis, chromatin condenses to form 
chromosomes in prophase. In metaphase, the replicated chromatids line up along the center of 
the cell by attaching to the fibers of the mitotic spindle. During anaphase, the chromatid pairs 
are segregated, with each strand of a pair moving to an opposing site of the cell. Division of the 
nucleus completes in telophase, when a new membrane forms around each of the two groups 
of chromosomes (http://www.houghtonmifflinbooks.com/booksellers/press_release/student 
science/gif/mitosis1.gif). 
 
1.1.3 Cell cycle checkpoints and the DNA damage response 
To ensure proper cell cycle progression and thus maintain genomic integrity, the 
mammalian cell cycle harbors a number of checkpoints that monitor fidelity and 
completion level of each of the cell cycle phases (Bartek & Lukas, 2007). Upon DNA 
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damage or incomplete DNA replication, these cell cycle checkpoints are activated, 
leading to a transient inhibition of cell cycle progression and allowing for repair of any 
defects. During the DNA damage response (DDR), DNA lesions are sensed as well as 
defects in chromosome segregation and spindle assembly. Sensing of these errors 
ultimately leads to a cell cycle arrest by inhibition of the CDKs. Cell cycle checkpoints 
monitor G1/S transition, intra S phase, G2/M transition and spindle assembly during 
mitosis. 
The key regulators for the response to DNA damage are the ataxia-telangiectasia-
mutated (ATM) and Rad3-related (ATR) serine/threonine protein kinases. ATM/ATR 
accumulate at sites of DNA damage where they are subsequently activated (Shiloh, 
2001; Bartek & Lukas, 2007). ATM/ATR transduce the DNA damage signal by 
phosphorylating the checkpoint kinases Chk1 and Chk2 and the histone variant H2AX 
(Sancar et al, 2004). Chk1, in turn, phosphorylates the CDC25 family phosphatases, 
WEE1 kinase and polo-like kinase 1 (PLK1; Fig. 1.2). 
 
 
Figure 1.2: Chk1 regulation of cell cycle progression.  Chk1 controls cell cycle progression 
by inhibiting PLK1 and CDC25 phosphatases, and activating WEE1 kinase. WEE1 
phosphorylates and thereby inhibits CDK1, whereas CDC25 phosphatases dephosphorylate 
and thus activate CDK1. PLK1 can activate CDK1 by inhibiting WEE1 and it can directly 
promote cell cycle progression (adopted from Patil et al, 2013). 
 
CDC25 phosphatases dephosphorylate CDKs in their ATP-binding loop, leading to the 
activation of CDKs and thus cell cycle progression (Donzelli & Draetta, 2003). 
However, upon phosphorylation by Chk1, CDC25 phosphatases are inactivated to 
arrest the cell cycle. In mammalian cells, there are three CDC25 isoforms named 
CDC25A, CDC25B and CDC25C, all of which are phosphorylated by Chk1 during the 
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DDR (Fig. 1.3). While CDC25A governs G1/S transition, S phase progression and 
G2/M transition, CDC25B and CDC25C primarily regulate G2/M transition (Donzelli & 
Draetta, 2003; Patil et al, 2013). 
Upon phosphorylation of S123 by Chk1, CDC25A is targeted for ubiquitin-dependent 
proteasomal degradation, which leads to the inhibition of CDK1 causing a cell cycle 
arrest at G1/S transition, S phase and G2/M transition (Patil et al, 2013). Proteasome-
targeting ubiquitylation of CDC25A is mediated by the Skp1-Cul1-F-box (SCF) βTrCP 
ubiquitin ligase in S and G2 phase (Busino et al, 2003). In addition to direct 
phosphorylation of CDC25A, Chk1 activates the NIMA-related kinase 11 (Nek11), 
which also phosphorylates CDC25A and thus further amplifies the DDR-induced cell 
cycle arrest (Melixetian et al, 2009). In contrast to CDC25A, Chk1-mediated 
phosphorylation of CDC25B and CDC25C leads to their inactivation by spatial 
translocation instead of degradation. Following their phosphorylation, CDC25B and 
CDC25C bind to 14-3-3 proteins which results in centrosomal sequestration of 
CDC25B and nuclear exclusion of CDC25C, respectively (Patil et al, 2013). 
 
 
Figure 1.3: Chk1-mediated cell cycle arrest in response to DNA damage. Chk1 
phosphorylates CDC25 phosphatases which causes their inhibition. Chk1 can additionally 
activate Nek11 kinase, which further phosphorylates CDC25A to target it for ubiquitin-
dependent degradation. CDC25A governs G1/S transition, S phase progression, and mitotic 
entry. Thus, its degradation leads to G1 arrest, G2 arrest, and delayed S phase. 
Phosphorylation of CDC25B induces its binding to 14-3-3 protein and subsequent centrosomal 
exclusion. Chk1 also phosphorylates CDC25C thereby promoting its association with 14-3-3 
protein and nuclear exclusion. CDC25B and CDC25C inhibition mainly results in G2 arrest 
(adopted from Patil et al, 2013). 
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Besides the CDC25 phosphatases, Chk1 targets WEE1, the protein kinase which 
mediates the inhibitory phosphorylation of CDK1 at Y15 (Fig. 1.2). In response to DNA 
damage, phosphorylation and activation of WEE1 by Chk1 results in the inhibition of 
CDK1 activity and cell cycle arrest in G2 phase (O'Connell, 1997).  
Furthermore, Chk1 negatively regulates PLK1, a mitotic kinase which is involved in 
centrosome maturation, spindle formation and cytokinesis (Tang et al, 2006). PLK1 
phosphorylates WEE1 and targets it for degradation, which causes CDK1-cyclin B 
complex activation and initiation of the G2/M transition (Watanabe et al, 2005). Upon 
DNA damage, Chk1-mediated phosphorylation of PLK1 leads to its inhibition, thus 
WEE1 is stabilized and the cell cycle arrests in G2 phase.  
In addition to the activation of the checkpoint kinases, ATM phosphorylates and 
thereby activates the tumor suppressor p53, which leads to transcription of the CDK 
inhibitor p21 and a subsequent cell cycle arrest (Löbrich & Jeggo, 2007). This 
transcription- and translation-dependent pathway is slower than the fast activation of 
the checkpoint kinases that depends on phosphorylation and dephosphorylation events 
as well as ubiquitylation. 
 
1.2 The ubiquitin-proteasome system 
The covalent attachment of the small modifier protein ubiquitin (8 kDa) to proteins is a 
major regulatory mechanism for governing protein function and is indispensable for a 
functional cell cycle. This process called ubiquitylation (or ubiquitination or 
ubiquitinylation) is essential for the precise spatial and temporal proteolysis of key 
regulators of the cell cycle, thereby ensuring unidirectionality of the cell cycle. 
 
1.2.1 Ubiquitin ligases 
Ubiquitylation is ATP-dependent and requires the sequential action of three classes of 
enzymes (Fig. 1.4). First, the C-terminus of free ubiquitin is activated by a ubiquitin-
activating enzyme (E1). Ubiquitin is then passed to a ubiquitin-conjugating enzyme 
(E2) and is finally conjugated to a lysine residue of the target protein via an isopeptide 
bond by an E3 ubiquitin ligase (Hershko & Ciechanover, 1998). This monoubiquitin can 
be extended to polyubiquitin chains by adding additional ubiquitin moieties to the first 
one. Ubiquitin itself has seven lysines, which can participate in the formation of 
polyubiquitin chains (K6, K11, K27, K29, K33, K48 and K63), as well as the N-terminal 
methionine (Johnson et al, 1995; Peng et al, 2003; Behrends & Harper, 2011). The 
different ubiquitin linkages which can be linear or branched have diverse topologies 
and functions. For example, K11- and K48-linked chains usually target proteins for 
proteasomal degradation (Baboshina & Haas, 1996; Haglund & Dikic, 2005). In 
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contrast, monoubiquitin and other types of chains have non-degradative functions or 
target proteins and larger structures to the lysosome by endolysosomal sorting or 
autophagy. Further modulation of ubiquitin chains occurs by deubiquitinating enzymes 
(DUBs) which are able to hydrolyze ubiquitin bonds, thereby reversing ubiquitylation of 
target proteins and recycling ubiquitin (Reyes-Turcu et al, 2009). 
Specificity of protein ubiquitylation is conferred by more than 600 different E3 ubiquitin 
ligases encoded in the human genome (Li et al, 2008). These human E3 ubiquitin 
ligases are subdivided into two major classes, the homologous to the E6-AP C-
terminus (HECT) E3 ligases and the really interesting new gene (RING) E3 ligases 
(Rotin & Kumar, 2009; Metzger et al, 2012). For HECT E3 ligases, ubiquitin transfer 
from the E2 enzyme to the substrate involves a thioester intermediate with the active-
site cysteine of the E3. In contrast, RING E3s catalyze the direct transfer of ubiquitin 
from the E2 enzyme to the substrate by bringing them into close proximity (Metzger et 
al, 2012). 
 
 
Figure 1.4: Schematic illustration of the ubiquitin-proteasome system. Ubiquitylation 
requires the sequential action of a ubiquitin-activating enzyme E1, a ubiquitin-conjugating 
enzyme E2, and an E3 ubiquitin ligase. First, ubiquitin (Ub) is activated and transferred to the 
E1 in an ATP-dependent manner. Subsequently, the activated ubiquitin is conjugated to the E2. 
Then the E2-loaded ubiquitin is transferred to a substrate, catalyzed by an E3 ligase. E3 ligases 
are divided into HECT or RING ligases. Substrates can be mono- or polyubiquitylated with 
diversely linked ubiquitin chains, which determines the biological outcome ranging from protein 
degradation to non-proteolytic functions including NF-κB signaling, DNA repair or endocytosis 
(adopted from Zhang et al, 2014). 
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The vast majority of human E3 ubiquitin ligases belong to the RING ligases and among 
them, with up to 240 complexes, cullin-RING ligases (CRLs) constitute the largest 
group accounting for >40% of all ubiquitin ligases and about 20% of protein 
degradation via the proteasome (Soucy et al, 2009). CRLs are multisubunit complexes 
composed of three core components – a RING finger protein that mediates binding to 
ubiquitin-conjugating enzymes (E2), a cullin that serves as a scaffold, and a cullin-
specific adaptor protein (Deshaies & Joazeiro, 2009). Higher eukaryotes express seven 
different canonical cullins (CUL1, 2, 3, 4A, 4B, 5 and 7) that, with the exception of 
CUL3 based CRLs, bind to diverse cullin-specific adaptor proteins. The latter, in turn, 
associate with interchangeable substrate specificity factors, which then recruit 
substrates for ubiquitination. Activation of CRLs is stimulated by the covalent 
attachment of a ubiquitin-like molecule, NEDD8, to a conserved lysine residue in the 
cullin (Duda et al, 2008; Saha & Deshaies, 2008), and continuous neddylation and 
deneddylation cycles are required for their proper function (Bosu & Kipreos, 2008). 
 
 
Figure 1.5: Schematic representation of cullin-RING ligase complexes. Cullin-RING ligase 
(CRL) complexes are composed of a cullin that serves as the complex scaffold, and a RING-
finger protein (Rbx1) that recruits an E2 enzyme for substrate ubiquitylation. Moreover, CRLs 
have a variable adaptor protein that links the substrate receptor to the cullin placing the 
substrate and the E2 in close proximity. S, substrate; Skp1, S phase kinase associated protein 
1; FBP, F-box protein; EloB, Elongin B; EloC, Elongin C; VHL, von-Hippel-Landau; DDB1, DNA 
damage binding protein 1; DCAF, DDB1 and Cul4-associated factors; Ub, ubiquitin (modified 
from Mahon et al, 2014). 
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CUL1, CUL2 and CUL4 are all implicated in the regulation of eukaryotic replication 
and/or S phase progression (Cukras et al, 2014; Feng et al, 1999; Craney & Rape, 
2013).  
CRLs which are based on cullin 1 as the scaffold are also named CRL1 or SCF ligases 
(Fig. 1.5). They contain a RING-box protein 1 (Rbx1), which recruits the E2 enzyme, 
and the S phase kinase associated protein 1 (Skp1) as the cullin-specific adaptor 
protein that binds the substrate-binding F-box protein (Zheng et al, 2002). In humans, 
69 different F-box proteins target diverse sets of substrates, thereby contributing to the 
broad functional range of the SCF ligase (Skaar et al, 2009; Silverman et al, 2012). 
One of the F-box proteins that have been linked to the regulation of cell cycle 
progression is βTrCP. There are two orthologs, βTrCP1 and βTrCP2 (also known as 
Fbxw11), which are biochemically indistinguishable and referred to as βTrCP1/2 or 
simply βTrCP. It binds to substrate phosphodegrons via WD40 repeats in its C-
terminus. Among others, βTrCP is implicated in the DDR, where it mediates 
degradation of the CDC25A phosphatase (Kanemori et al, 2005). 
In contrast, CUL2-Rbx1 interacts with VHL and Elongin B and C to mediate the 
degradation of the hypoxia-inducible transcription factor HIF1α (Pause et al, 1997; 
Kamura, 1999; Ohh et al, 2000; Hwang et al, 2015). 
CUL4 was shown to be involved in nucleotide excision repair (NER). The CUL4-Rbx1 
complex associates with the global genome NER-associated factor DNA damage 
binding protein 2 (DDB2) or the transcription-coupled NER-associated factor Cockayne 
syndrome complementary group A (CSA) to form similar E3 ubiquitin ligase complexes 
(Shiyanov et al, 1999; Groisman et al, 2003). Following exposure to ultraviolet (UV) 
light, DDB2 recognizes UV lesions and binds tightly to the DNA damage binding protein 
1 (DDB1), thereby recruiting the ubiquitin ligase CUL4-DDB1 to photolesion sites. At 
lesion sites, CUL4-DDB1 ubiquitylates DDB2, the UV damage sensor xeroderma 
pigmentosum group C (XPC), and histones H2A, H3 and H4 around the site of damage 
(Sugasawa et al, 2005; El-Mahdy et al, 2006; Kapetanaki et al, 2006; Wang et al, 
2006). Ubiquitylation of histones H3 and H4 was shown to loosen nucleosome binding 
in vitro (Wang et al, 2006), providing space for NER proteins in the otherwise 
inaccessible chromatin environment.  
When the RNA polymerase II encounters UV lesions during transcription, it stalls and is 
proteolytically released from chromatin with the help of the Cockayne syndrome 
complementary group A and B (CSA and CSB; Bregman et al, 1996; Svejstrup, 2002; 
Anindya et al, 2007). CSA binds RNA polymerase II in a UV-dependent manner 
(Kamiuchi et al, 2002; Groisman et al, 2003). Moreover, CSA associates with CUL4-
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DDB1 to form an E3 ubiquitin ligase (Groisman et al, 2003) and ubiquitylates CSB, 
resulting in its proteasomal degradation (Groisman, 2006). 
Furthermore, CUL4-DDB1 together with the substrate receptor CDT2 is responsible for 
ubiquitylation of the replication licensing factor CDT1 and its subsequent turnover by 
the proteasome (Hu et al, 2004; Jin et al, 2006; Higa et al, 2006). CDT2 is recruited to 
replication forks by PCNA-bound CDT1 (Jin et al, 2006) and associates with CUL4-
DDB1 to form a ubiquitin ligase that mediates CDT1 ubiquitylation. 
Another prominent E3 ubiquitin ligase involved in cell cycle regulation is the anaphase 
promoting complex/cyclosome (APC/C). APC/C activity is restricted to the period 
between metaphase and the end of G1. It associates with one of its two substrate-
specific adaptors Cdc20 and Cdh1 dependent on the stage of mitosis. APC/CCdc20 is 
responsible for anaphase onset and mitotic exit, whereas APC/CCdh1 participates in the 
final stages of mitosis and establishes a stable G1 state (Acquaviva, 2006; Li & Zhang, 
2009). 
 
1.2.2 The proteasome 
The proteasome is one of the major cellular structures responsible for the degradation 
of dispensable or defective proteins by proteolysis, which is the hydrolysis of peptide 
bonds. In this process, proteases break down proteins into peptides of typically seven 
to nine amino acids that can be further degraded and recycled for the synthesis of new 
proteins (Voges et al, 1999). The proteasomal degradation pathway is substantial for 
diverse cellular processes, including the cell cycle and the cellular response to DNA 
damage. Proteasomes are present in all eukaryotes and archaea as well as in some 
bacteria. In eukaryotes, they are located in the nucleus and the cytoplasm (Peters et al, 
1994). In mammals, the most common form is the 26S proteasome, which contains a 
20S protein core subunit and two 19S regulatory subunits that cap each end of the core 
(Fig 1.6). 
The 20S core subunit of the proteasome has a cylindrical structure consisting of four 
stacked hetero-heptameric rings forming a central pore (Lowe et al, 1995; Groll et al, 
1997). The two inner rings are composed of seven β subunits which bear protease 
activity. The active sites of the proteases reside at the inward facing surface of the 
rings so that target proteins have to enter the central pore for degradation. In 
mammals, the subunits β1, β2, and β5 are catalytically active with three distinct 
substrate specifities which are considered to be chymotrypsin-like, trypsin-like and 
peptidylglutamyl-peptide hydrolyzing (Heinemeyer et al, 1997). The two outer rings are 
composed of seven α subunits forming a gate that inhibits uncontrolled entry of 
substrates to the interior cavity (Smith et al, 2007). Moreover, the α subunits associate 
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with the 19S regulatory subunits, which harbor multiple ATPase active sites and 
ubiquitin binding sites to recognize polyubiquitylated proteins with at least four 
ubiquitins and target them to the catalytic core (Thrower, 2000; Liu et al, 2006). ATP 
binding to the 19S subunit stimulates substrate binding, association of the 19S to the 
20S subunit and gate opening (Köhler et al, 2001; Smith et al, 2005; Liu et al, 2006) by 
docking of the C-terminal HbYX motif of the 19S ATPases into pockets of the 20S 
alpha rings (Smith et al, 2007). The narrow entrance of the proteasome (13 Å) 
demands that substrate proteins have to be at least partially unfolded already prior to 
entry (Coux et al, 1996; Larsen & Finley, 1997; Verhoef et al, 2008). Upon ATP 
hydrolysis, polyubiquitylated substrate proteins are unfolded, deubiquitylated and 
subsequently translocated to the interior of the proteasome (Zhu et al, 2005; Liu et al, 
2006). Proteasomal degradation can be supported by ubiquitin receptors that escort 
polyubiquitylated proteins to the proteasome (Elsasser & Finley, 2005). These 
receptors have ubiquitin-associated (UBA) domains to bind ubiquitylated substrate 
proteins and ubiquitin-like (UBL) domains that are recognized by the 19S proteasome. 
 
 
Figure 1.6: The structure of the 26S proteasome. The 26S proteasome contains a 20S core 
subunit and two 19S regulatory subunits attached to each end of the core. The 20S core 
consists of four hetero-heptameric rings. The two outer rings are composed of seven distinct α 
subunits (red), the two inner rings of seven distinct β subunits (orange and yellow). The subunits 
β1, β2, and β5 have protease activity (yellow). The 19S regulatory particle consists of a base 
and a lid (blue). The base harbors multiple ATPases (green; http://www.bostonbiochem.com/ 
products/proteasome). 
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1.3 The AAA ATPase p97 is part of the ubiquitin-proteasome 
system 
Downstream of ubiquitylation, ubiquitin receptors recognize the substrate proteins with 
K11- or K48-polyubiquitin chains and facilitate their degradation by the proteasome 
(Verma et al, 2004). One key regulator in facilitation of proteasomal degradation is the 
AAA protein family member valosin-containing protein (VCP)/p97 (also called Cdc48 in 
yeast and plants, CDC-48 in worms, and Ter94 in flies). p97 is an essential and highly 
abundant protein sharing 69% sequence identity from yeast to human (Fröhlich et al, 
1991). 
Mechanistically, p97 acts as a ubiquitin-selective chaperone as it catalyzes the 
segregation of ubiquitylated substrates from protein complexes, aggregates, or 
membranes and thereby facilitates their degradation (Fig. 1.7; Rape et al, 2001; Meyer, 
2002; Shcherbik & Haines, 2007). The energy required for this segregase activity 
derives from ATP hydrolysis, which is coupled with conformational changes of p97 
itself (Rouiller et al, 2002). These changes result in conformational remodeling or 
unfolding of substrate proteins, thereby assisting proteasomal degradation (Yamanaka 
et al, 2012). 
 
 
Figure 1.7: General model for p97 in substrate segregation and ubiquitin chain editing. 
Ubiquitin (orange) is post-translationally attached to substrate proteins (S) by a cascade of a 
ubiquitin-activating enzyme E1, a ubiquitin-conjugating enzyme E2, and an E3 ubiquitin ligase. 
p97 binds to ubiquitylated substrates via ubiquitin-binding cofactors (C). Then, p97 uses the 
energy of ATP hydrolysis to segregate the substrate from binding partners (B) or cellular 
surfaces. Interactions with ubiquitin-editing factors, like E4 chain extension factors or 
deubiquitylating enzymes (DUBs), are able to modify ubiquitin chains to either recycle the 
substrate or target it to the proteasome (Pr) for degradation (adopted from Meyer et al, 2012). 
 
1.3.1 Structure and activity of p97 
p97 is a homo-hexameric protein. Each protomer consists of a globular N-terminal 
domain, the two ATPase domains D1 and D2, and a disordered C-terminal tail 
(DeLaBarre & Brunger, 2003). Two linker regions connect the N and D1 as well as the 
D1 and D2 domains, respectively. Both ATPase domains contain a Walker A and 
Walker B motif, which are important for ATP binding and hydrolysis, respectively. 
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Hexamerization is essential for p97 activity and is promoted by ATP binding to the D1 
domain (Wang et al, 2003). 
The three-dimensional structure of hexameric p97 has been investigated by X-ray 
crystallography, small angle X-ray scattering (SAXS) and electron microscopy (EM; 
Fig. 1.8). These studies revealed that p97 has two stacked rings consisting of the D1 
and D2 ATPase domains, respectively, whereas the N domains protrude from the 
periphery of the D1 ring (DeLaBarre & Brunger, 2003; Dreveny et al, 2004). 
 
 
Figure 1.8: The structure of the hexameric AAA protein p97. Each subunit consists of a 
globular N-terminal domain (green), the two AAA ATPase domains D1 (cyan) and D2 (blue), 
and a C-terminal tail (gray). D1 and D2 form two stacked hexameric rings, while the N domain 
resides at the periphery of the D1 ring. The crystal structure was generated by PyMOL using the 
PDB id: 1R7R (adopted from Meyer et al, 2012). 
 
The latest Cryo-EM study on p97 structure discriminates three distinct conformations of 
p97, depending on the binding of nucleotides (Banerjee et al, 2016). In conformation I, 
ADP is bound to D1 and D2 domains. Concomitantly, the N domains are coplanar with 
the D1 ring (also called down conformation or locked conformation in other studies; 
Niwa et al, 2012; Yeung et al, 2014). Upon ATP binding to the D2 domain, the N-D1 
and D2 hexameric rings rotate relatively to each other, resulting in conformation II (Noi 
et al, 2013; Yeung et al, 2014; Banerjee et al, 2016). Additional binding of ATP to D1 
finally induces a conformational switch to conformation III (Banerjee et al, 2016). In 
conformation III, the N domain is released from the D1 plane and adopts a state above 
the D1 ring (also called up conformation or flexible conformation; Niwa et al, 2012; 
Yeung et al, 2014). Cryo-EM studies of different p97 complexes demonstrated that in 
this conformation, cofactors of p97 can bind to the N domain (Beuron et al, 2006; 
Bebeacua et al, 2012; Ewens et al, 2014). Moreover, the D2 pore is contracted in 
comparison to the other conformations (Yeung et al, 2014; Banerjee et al, 2016). 
Notably, the D1 ring hydrolyzes ATP at a lower rate than the D2 ring (Fang et al, 2015). 
This discrepancy might be based on very tight binding of ADP to the D1 ring 
(DeLaBarre & Brunger, 2003; Huyton et al, 2003; Briggs et al, 2008). Still, ATP 
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hydrolysis of the D1 domain is important for p97 function since a point mutation in the 
D1 Walker B motif, which abrogates ATP hydrolysis, is lethal (Ye et al, 2003; Esaki & 
Ogura, 2010). 
While it seems clear that ATP hydrolysis implies conformational changes of p97 that 
create mechanical force allowing substrate unfolding, dissociation or remodeling, the 
underlying mechanism is still controversial. There are studies speculating that p97 
unfolds ubiquitylated proteins by threading them completely through its central pore (Ye 
et al, 2003; Rothballer et al, 2007; Barthelme & Sauer, 2013; Tonddast-Navaei & Stan, 
2013). Yet, the crystal structure of p97 revealed that the axial pore of the D1 ring is 
severely constrained by a zinc-ion coordinated to multiple H317 side chains 
(DeLaBarre & Brunger, 2003). Thus, it was proposed that substrate unfolding occurs by 
interaction with an external surface region of p97 rather than by translocation through 
the central pore. However, it is unclear if the pore block also exists in solution. An 
alternative model suggests that substrates are only threaded through the axial pore of 
the D2 ring to avoid the D1 pore block (DeLaBarre et al, 2006). Though, an unfoldase 
activity of p97 was so far only observed upon simultaneous deletion of the N domain 
and mutation of the D1 ring pore residues to tyrosines (Rothballer et al, 2007; 
Barthelme & Sauer, 2013). Moreover, some chromatin-associated p97 targets remain 
active after segregation suggesting that p97 activity does not necessarily involve 
substrate unfolding. Yet, it was shown that the degradation of a substrate with an 
unstructured C-terminus is no longer dependent on p97 activity (Beskow et al, 2009). A 
recent study claims that p97 can indeed unfold polyubiquitylated proteins and that this 
process is ATP-independent (Song et al, 2015). 
In addition to the mechanism of substrate unfolding and dissociation, the interaction of 
p97 and the proteasome remains elusive. The C-terminus of archaeal p97 terminates 
with an HbYX motif that might mediate the direct association with the 20S proteasome 
(Barthelme & Sauer, 2012; Barthelme & Sauer, 2013). Thus, p97 could identify and 
thread substrates into the proteolytic chamber of the proteasome for hydrolysis. In 
yeast, however, p97 hands substrates over to other shuttling factors, Rad23 and Dsk2, 
which then target the substrates to the proteasome (Richly et al, 2005). In contrast, 
studies with human p97 suggest direct binding of p97 to the proteasome (Alexandru et 
al, 2008; Verma et al, 2011). 
 
1.3.2 Biological functions of p97 
p97 accounts for more than 1% of cytosolic proteins (Ye, 2006) and accordingly plays a 
role in a large variety of independent cellular processes (Meyer et al, 2012). The main 
role of p97 is to ensure protein homeostasis. The best studied function of p97 is in 
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endoplasmic reticulum-associated degradation (ERAD; Kothe et al, 2005). p97 is 
important for coordinating retrotranslocation of misfolded proteins from the ER to the 
cytosol, their ubiquitylation and subsequent degradation by the proteasome. In addition 
to its well established role in ERAD, which results in proteasomal degradation, p97 has 
been linked to the other major cellular degradative system, the lysosome. p97 is 
implicated in endolysosomal and autophagolysosomal pathways, where it mediates the 
sorting of cargo proteins (Ju & Weihl, 2010; Ritz et al, 2011; Meyer et al, 2012; 
Kirchner et al, 2013). Furthermore, p97 is responsible for the maturation of 
autophagosomes and inclusion body formation (Tresse et al, 2010). Moreover, p97 is 
involved in chromatin-associated degradation, where it governs cell cycle progression 
and the DDR (Dantuma & Hoppe, 2012). Besides, p97 regulates apoptosis through 
degradation of key apoptotic factors, such as Mcl1 or DIAP1 (Rumpf et al, 2011; Xu et 
al, 2011). Furthermore, p97 was implicated in mitochondria-associated degradation. It 
is critical for protein quality control at the outer mitochondrial membrane and regulates 
mitochondrial membrane fusion and destruction of mitochondria through mitophagy 
(Heo et al, 2010; Tanaka et al, 2010; Wild & Dikic, 2010; Livnat-Levanon & Glickman, 
2011; Xu et al, 2011). Recently, p97 was found to play a role in ribosome-associated 
degradation, where it co-translationally eliminates misfolded nascent peptides, which 
may comprise up to about 30% of newly synthesized proteins (Brandman et al, 2012; 
Fujii et al, 2012; Verma et al, 2013). Thus, it is directly involved in ribosome-associated 
protein quality control and the translational stress response. In addition, p97 is critical 
for lysosomal destruction of the ribosomal component Rpl25 upon starvation in a 
process called ribophagy (Ossareh-Nazari et al, 2010). Additionally, p97 participates in 
the regulation of signaling processes. For instance, p97 is required to selectively 
separate the transcription factor NF-κB from its polyubiquitylated inhibitor IκBα. As a 
result, NF-κB is released to enter the nucleus and activate transcription, while IκBα is 
degraded (Dai, 1998). Another p97 substrate in signaling processes is the hypoxia-
inducible factor 1α (HIF1α), of which degradation is induced by CUL2VHL-mediated 
ubiquitylation and results in down-regulation of the hypoxic response (Alexandru et al, 
2008). However, the removal of a ubiquitylated substrate from a protein complex or a 
subcellular structure is not necessarily linked to subsequent (proteasomal) degradation. 
p97 is also implicated in proteasome-independent membrane trafficking events, 
including Golgi reassembly after mitosis, where p97 promotes membrane-protein 
segregation (Kondo et al, 1997; Meyer, 2005). Moreover, p97 has been shown to 
control lipid droplet biogenesis (Olzmann et al, 2013). 
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1.3.3 p97 cofactors 
Alternative cofactors have been described that define the pathway-specific functions of 
p97 (Yeung et al, 2008). So far, about 40 p97 cofactors have been identified that link 
p97 to specific pathways and substrates. Although p97 is able to bind ubiquitin directly 
in vitro, in vivo p97 requires the binding of substrate-recruiting cofactors to obtain 
optimal activity (Meyer, 2002; Ye et al, 2003). These substrate-recruiting factors link 
p97 to its ubiquitylated substrates via ubiquitin-binding domains and thus, mediate a 
more stable enzyme-substrate complex (Meyer, 2002). For some cofactors, it was 
shown that the substrate-recruiting factor binds to the substrate before p97 recruitment 
(Madsen et al, 2009), while other adaptor proteins first assemble with p97 to create a 
complex that is able to bind ubiquitylated substrates. 
Apart from interacting with diverse substrate-recruiting cofactors, p97 also associates 
with a large variety of substrate-processing cofactors, including DUBs. p97-associated 
DUBs are either able to prevent p97 substrates from degradation or they can promote 
substrate degradation by modulating ubiquitin chains to those types that are 
recognized by the proteasome (Rumpf & Jentsch, 2006). Several DUBs have been 
found to interact with p97, for example VCIP135, which regulates the p97-mediated 
Golgi and ER membrane fusion (Uchiyama, 2002; Wang et al, 2004; Zhang et al, 
2013), YOD1 (and its yeast ortholog Otu1), USP13, ataxin3 and USP25, which are 
linked to the regulation of ERAD (Rumpf & Jentsch, 2006; Ernst et al, 2009; Sowa et al, 
2009; Blount et al, 2012; Liu et al, 2014), and USP50, which has been implicated in the 
regulation of the DNA damage checkpoint (Sowa et al, 2009; Aressy et al, 2014). 
Cofactor binding to the N-terminus of p97 can be promoted by different domains (Fig. 
1.9), including the ubiquitin regulatory X (UBX) domain, the UBX-like (UBX-L) domain, 
or short binding motifs like the SHP box (also called binding site 1, BS1), the VCP-
binding motif (VBM) or the VCP-interacting motif (VIM; Meyer, 2002; Buchberger, 2010; 
Kloppsteck et al, 2012; Meyer et al, 2012). Other cofactors bind to the C-terminal tail of 
p97 via their PUB (peptide N-glycosidase/UBA or UBX containing proteins; also known 
as PUG) or PUL (PLAA, Ufd3, and Lub1) domains (Madsen et al, 2009). 
In mammals, the largest group of p97 cofactors is constituted by the 13 UBX proteins 
(p37, p47, UBXD1-8, FAF1, SAKS1, and ASPL). Apart from UBXD1, they bind p97 via 
a highly conserved FPR motif of their UBX domain, which features a ubiquitin-like fold 
(Buchberger et al, 2001; Dreveny et al, 2004; Schuberth & Buchberger, 2008). UBXD1 
instead lacks the conserved FPR motif and interacts via its VIM and its PUB domain 
with the N domain and the C-terminus of p97, respectively (Kern et al, 2009). Recently, 
a further p97-binding site at the N-terminus of UBXD1 was identified (Trusch et al, 
2015). While eight of the UBX proteins (p37, ASPL, UBXD1 to UBXD6) are referred to 
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as UBX-only proteins, the other five (p47, UBXD7, UBXD8, FAF1, and SAKS1) also 
have an N-terminal ubiquitin-associated UBA domain, classifying them as UBA-UBX 
proteins (Alexandru et al, 2008; Schuberth & Buchberger, 2008). The UBA domain is 
involved in binding of ubiquitylated substrates. In addition to p97-binding, the UBA-UBX 
proteins also interact with E3 ubiquitin ligases, including cullins 1 through 4, nine RING 
ligases, and three HECT domain enzymes (Alexandru et al, 2008). 
 
 
Figure 1.9: Domain structure of selected p97 adaptor proteins. UBX or UBX-L domains or 
short motifs such as the binding site 1 motif (BS1, also called SHP), the VCP-interacting motif 
(VIM) or the VCP-binding motif (VBM) interact with the N domain of p97. PUB (peptide N-
glycosidase/UBA or UBX containing proteins) or PUL (PLAA, Ufd3 and Lub1) domains bind the 
C-terminus of p97. The ubiquitin-associated (UBA) domain, the Npl4 zinc finger (NZF), the 
ubiquitin-interacting motif (UIM), the Ufd1 truncation 3 (UT3) and the UBZ are able to bind 
ubiquitin. The ovarian tumor (OTU) domain has deubiquitylating activity. SEP, Shp1-eyc-p47 
domain; UAS, ubiquitin-associating domain; SprT, potential zinc binding domain; PIP, PCNA-
interacting protein motif; aa, amino acids. 
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Some adaptor proteins, like p47, UBXD1 and the heterodimer Ufd1-Npl4, target 
identical or overlapping sites on p97. Thus, they bind to p97 in a mutually exclusive 
manner (Meyer et al, 2000; Bruderer et al, 2004). However, simple competition for p97-
binding sites is not the only determinant in cofactor selectivity since these protein 
complexes can combine with additional cofactors to form higher-order protein 
complexes (Alexandru et al, 2008; Schuberth & Buchberger, 2008). These additional 
cofactors can alter p97 localization and provide additional enzymatic activity and 
thereby further specify p97 functions. Three p97 cofactors have been linked to 
chromatin-associated p97 functions, namely the Ufd1-Npl4 heterodimer, UBXD7, and 
DVC1. 
 
Ufd1-Npl4 
The best studied p97 cofactor is the heterodimeric Ufd1-Npl4 ubiquitin adaptor. In 
yeast, this is the only essential cofactor (Johnson et al, 1995; DeHoratius & Silver, 
1996). The nuclear protein localization 4 (Npl4) binds to the ubiquitin fusion 
degradation 1 protein (Ufd1) in a 1:1 stoichiometry (Meyer et al, 2000; Bruderer et al, 
2004). In the absence of Npl4, Ufd1 is unstable (Bruderer et al, 2004; Dobrynin et al, 
2011). Studies revealed that ATP binding to the D1 domain regulates the recruitment of 
p97 adaptor proteins to the N domain including Ufd1-Npl4 (Chia et al, 2012). Ufd1-Npl4 
binds to p97 in a 1:6 stoichiometry (Pye et al, 2007). The N domain of Ufd1 shows 
structural similarity to the N domain of p97 and contains binding sites for both mono- 
and polyubiquitin (Park et al, 2005). In contrast, Npl4 comprises an N-terminal UBX-L 
domain and a C-terminal zinc-finger (NZF), which binds to K48 and K63 polyubiquitin 
chains (Meyer, 2002; Ye et al, 2003; Bruderer et al, 2004; Isaacson et al, 2007). Like 
UBXD1, Ufd1-Npl4 binds to p97 in a bipartite manner, involving the p97-interacting 
UBX-L domain of Npl4 and the BS1 motif of Ufd1 (Bruderer et al, 2004). A 3D electron 
cryomicroscopy reconstruction of the p97Ufd1-Npl4 complex showed that this complex is 
highly dynamic and that Ufd1-Npl4 assumes distinct positions relative to the p97 ring 
upon addition of a nucleotide (Bebeacua et al, 2012). In complex with Ufd1-Npl4, p97 
acts in cellular pathways as diverse as ERAD, activation of transcription factors and 
chromatin-associated degradation of proteins. Among others, it is involved in the 
regulation of cell cycle progression and the regulation of the DDR. 
 
UBXD7 
In 2011, it was shown for the first time that UBXD7 (also called UBXN7) binds to the 
p97Ufd1-Npl4 complex, but not to free p97 (Hänzelmann et al, 2011). This demonstrates a 
hierarchy in cofactor binding to p97. It might be that binding of Ufd1-Npl4 induces 
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conformational changes in p97, resulting in an asymmetry of p97, which allows for tight 
interaction of UBXD7 with only one of the vacant p97 subunits (Hänzelmann et al, 
2011). 
UBXD7 is the only p97 adapter with an ubiquitin-interacting motif (UIM), with which it 
directly binds to neddylated CRLs (Bandau et al, 2012; den Besten et al, 2012). 
UBXD7 comprises a ubiquitin-binding UBA domain, a ubiquitin-associating domain 
(UAS) of unknown function, the UIM and a p97-interacting UBX domain. A current 
model proposes that the UBA and UBX domains interact with each other intra- or 
intermolecularly, thereby maintaining UBXD7 in an inactive state. Only upon binding of 
a ubiquitylated substrate via the UBA domain, the UBX domain would become 
available to recruit the p97Ufd1-Npl4 complex. Thus, substrate binding to UBXD7 
precedes the formation of UBXD7 complexes with p97Ufd1-Npl4 and may be a 
prerequisite for complex formation (Alexandru et al, 2008). In addition, the UIM domain 
recognizes the ubiquitin-like small protein modifier NEDD8, which is dynamically 
conjugated to the cullin subunit of the CRL, thereby activating its ligase activity 
(Petroski & Deshaies, 2005; Saifee & Zheng, 2008). NEDD8 conjugation induces 
conformational changes in the CRL, which allow the RING domain of Rbx1 to spring 
free from the cullin and to position the ubiquitin-conjugating enzyme E2 in the vicinity of 
the substrate and thus promote ubiquitin transfer (Duda et al, 2008; Saha & Deshaies, 
2008; Saifee & Zheng, 2008). There is evidence that UBXD7 binds CUL2- and CUL4-
based CRLs preferentially over CUL1 and CUL3 (den Besten et al, 2012). 
In budding yeast, it was demonstrated that Cdc48Ufd1-Npl4 and the UBXD7 homologue 
Ubx5 are required for CUL3-dependent degradation of the largest subunit of RNA 
polymerase II, Rpb1, after UV treatment (Verma et al, 2011). In this case, Ubx5 links 
substrate ubiquitylation to p97-mediated extraction, which is important for subsequent 
degradation of this substrate by the proteasome. In human cells, UBXD7 together with 
p97 was shown to participate in turnover of HIF1α, a CUL2VHL substrate that is 
constitutively degraded under normoxic conditions (Alexandru et al, 2008). Intriguingly, 
while Ubx5 is required for efficient turnover of Rpb1 in yeast, depletion of UBXD7 in 
human cells accelerates HIF1α degradation. Consistently, overexpression of UBXD7 
inhibits HIF1α ubiquitylation dependent on the presence of the UIM. Here, UBXD7 
antagonizes substrate ubiquitylation and degradation. An explanation for this 
observation could be that UBXD7 attachment to neddylated CRLs might sterically 
hinder the transition of the CRL complex to an open conformation and thereby weaken 
the positive effect NEDD8 has on CRL E3 activity (Bandau et al, 2012). Indeed, 
UBXD7 binding interferes with recruitment of the E2 Cdc34 to the SCFβTrCP ligase and 
decreases substrate ubiquitylation (den Besten et al, 2012). 
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Thus, one study proposes that the function of UBXD7 is to inhibit the CRL, so that 
shorter ubiquitin chains are attached to substrate proteins which target them for p97-
dependent proteasomal degradation (Bandau et al, 2012). In contrast, the other study 
suggests that UBXD7 binding to CRLs only occurs if the ligase stalls, when it 
encounters a substrate which is difficult to extract from a binding partner or a 
subcellular structure (den Besten et al, 2012). In this case, UBXD7 would bind to 
NEDD8 and recruit p97 for substrate extraction. This provides an explanation as to why 
only certain substrates of CRLs require p97UBXD7. However, it does not explain why a 
subset of CRL substrates require p97 but not UBXD7 for degradation, as in the case of 
chromatin-bound CDT1, a replication licensing factor targeted by CUL4A (den Besten 
et al, 2012). 
Finally, an analysis of the functional implications of the chromosome 3q amplicon in 
lung squamous cell carcinoma (SCC) revealed that UBXD7 regulates cellular 
proliferation in lung SCC that harbor the amplicon (Wang et al, 2013). 
 
DVC1 
The p97 adaptor protein DVC1 (for DNA damage-targeting VCP/p97 adaptor C1orf124, 
also known as C1orf124 or Spartan) plays a role in translesion synthesis (Centore et al, 
2012; Davis et al, 2012; Ghosal et al, 2012; Juhasz et al, 2012; Machida et al, 2012; 
Mosbech et al, 2012; Kim et al, 2013). Moreover, it was shown that DVC1 is not 
recruited to DNA double-strand breaks (DSBs) and therefore not involved in DSB repair 
(Centore et al, 2012; Davis et al, 2012; Ghosal et al, 2012; Juhasz et al, 2012; 
Mosbech et al, 2012). DVC1 expression is restricted to S and G2 phase (Mosbech et 
al, 2012). Impairment of DVC1 was reported to increase UV light-induced mutagenesis 
(Machida et al, 2012) and leads to hypersensitivity towards replication stress-inducing 
agents in human cells and Caenorhabditis elegans (Juhasz et al, 2012; Mosbech et al, 
2012). Importantly, DVC1 deficiency was linked to genome instability, premature 
ageing and cancer predisposition both in humans (Lessel et al, 2014) and in mice 
(Maskey et al, 2014). 
DVC1 binds p97 via a SHP motif. Moreover, DVC1 contains an UBZ4-type ubiquitin-
binding domain and a PIP box with which it interacts with monoubiquitylated PCNA 
(Centore et al, 2012; Davis et al, 2012; Ghosal et al, 2012; Juhasz et al, 2012; Machida 
et al, 2012; Mosbech et al, 2012). In addition, DVC1 comprises a SprT-like domain 
bearing a HEXXH motif which is typical of metallopeptidases. Due to structural and 
functional similarities, some studies argue on DVC1 being the mammalian 
representative of the yeast weak suppressor of smt3-331 (Wss1), hence acting as a 
protease (Davis et al, 2012; Mosbech et al, 2012; Stingele et al, 2015). Wss1 is a DNA-
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dependent metalloprotease involved in the repair of DNA-protein crosslinks by cleaving 
them and thereby enabling helicase progression and translesion synthesis (Stingele et 
al, 2014). Wss1 is recruited to DNA lesion sites, where it binds to targets modified with 
the small ubiquitin-like modifier (SUMO). There, it catalyzes SUMO chain extension 
(Balakirev et al, 2015). Upon SUMO polymerization, more Wss1 is accumulated and its 
protease activity is activated (Balakirev et al, 2015). Wss1 cleaves itself and associated 
proteins in the repair complex, leading to extraction of the sumoylated proteins and 
subsequent proteasomal degradation (Balakirev et al, 2015). It forms a complex with 
Cdc48 and the Cdc48-adaptor protein Doa1 (Balakirev et al, 2015). However, so far no 
protease or metallopeptidase activity associated with the SprT domain of DVC1 has 
been detected. Yet, the SprT domain is essential for DVC1 function (Kim et al, 2013). 
 
1.4 The role of p97 and its cofactors in the cell cycle and the DNA 
damage response 
p97 has emerged as a central player in various chromatin-associated processes 
including cell cycle progression, DNA replication, transcription, and the DDR. The 
Cdc48 gene was identified in the first genetic screen for cell division cycle mutants in 
yeast (Moir et al, 1982). Several studies in yeast and other organisms have clearly 
demonstrated that Cdc48 is essential for cell cycle progression (Mouysset et al, 2008; 
Deichsel et al, 2009). In yeast, mutations in the Cdc48 gene result in delayed G1/S 
transition and G2/M arrest (Fu et al, 2003). In the nematode Caenorhabditis elegans, 
knockdown of CDC-48, or one of its cofactors UFD-1 or NPL-4, delays S phase 
progression due to activation of replication checkpoints (Mouysset et al, 2008). In 
human cell lines and Xenopus laevis egg extracts, inactivation of p97Ufd1-Npl4 causes 
delayed progression through anaphase and exit from mitosis (Ramadan et al, 2007; 
Dobrynin et al, 2011). All these observations highlight the pivotal role of p97 in protein 
degradation which is necessary for cell cycle progression. 
 
1.4.1 p97 in mitosis 
The first p97 substrate discovered in chromatin was Aurora B kinase that functions in 
the bipolar attachment of the mitotic spindle to the centromeres of chromosomes 
(Ramadan et al, 2007). In Xenopus laevis egg extracts and Caenorhabditis elegans, 
the p97Ufd1-Npl4 complex extracts Aurora B from chromatin at the end of mitosis, allowing 
chromatin decondensation and nuclear envelope formation. Importantly, although 
Aurora B extraction from chromatin is mediated by K48-linked polyubiquitin chains, 
chromatin dissociation is not coupled to degradation. Since Aurora B activity is 
stimulated by chromatin, it is possible that chromatin removal is sufficient to suppress 
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Aurora B (Kelly et al, 2007). In contrast, in human somatic cells, Aurora B is 
proteolysed after ubiquitylation by the ubiquitin ligase APC/CCdh1 (Stewart, 2005) at the 
exit of mitosis with the help of p97Ufd1-Npl4 (Dobrynin et al, 2011). Knockdown of Ufd1 or 
Npl4 increases Aurora B activity, which causes defects in chromosomal alignment in 
anaphase and subsequently missegregated chromosomes and multi-lobed nuclei. 
Thus, p97Ufd1-Npl4 antagonizes Aurora B activity. Interestingly, extraction of Aurora B 
from mitotic chromosomes during anaphase is regulated by the CRL3KLHL9-KLHL13 
ubiquitin ligase complex (Sumara et al, 2007) and its subsequent relocalization 
together with survivin to the midbody is governed by CRL3KLHL21 (Maerki et al, 2009). 
Recruitment of survivin at the centromere depends on K63 ubiquitin chains and the p97 
cofactor Ufd1, which indicates a role for p97Ufd1-Npl4 in survivin relocalization (Vong, 
2005). Similar to its role in mitosis, CDC-48 in Caenorhabditis elegans is essential for 
proper condensation and segregation of meiotic chromosomes by controlling AIR-
2/Aurora B (Sasagawa et al, 2012). Another p97 complex, Cdc48Shp1 (p97p47 in 
metazoans), counteracts Aurora B activity by facilitating localization of the Aurora B 
antagonist Glc7, the yeast ortholog of protein phosphatase-1 (PP1; Cheng & Chen, 
2010). Inactivation of Cdc48Shp1 results in a metaphase arrest due to erroneous 
kinetochore-spindle attachment and thus, activation of the spindle assembly 
checkpoint. In addition to Aurora B regulation, p97 together with its cofactors Ufd1 an 
Npl4 is crucial for proper spindle disassembly at the end of mitosis (Cao et al, 2003). 
Targets of p97Ufd1-Npl4 are spindle assembly factors XMAP215, TPX2, and Plx1, or in 
yeast, ase1 and Cdc5. Moreover, Cdc48UBXN2 and p97p37/p47 limit the association of 
Aurora A with centrosomes in nematodes and human cells, respectively (Kress et al, 
2013). 
 
1.4.2 p97 in G1/S transition 
In yeast, G1/S transition is governed by Cdc28/Cln, analogous to CDK-cyclin-
dependent cell cycle transition in mammals. Cdc28/Cln is antagonized by Far1p, which 
has to be degraded for G1/S progression and this degradation depends on Cdc48 (Fu 
et al, 2003). For eukaryotes, no similar p97-dependent process has been identified so 
far. However, in yeast, Cdc48Ufd1-Npl4 additionally regulates G1/S transition via cell wall 
integrity pathway mechanisms (Hsieh et al, 2011). The underlying mechanism remains 
unclear, although Cdc48 appears to regulate the activity of Mpk1, a MAP kinase family 
member essential for cell wall integrity, in response to stress conditions including heat 
shock (Hsieh et al, 2011). 
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1.4.3 p97 in DNA replication 
In addition to its role in mitosis and G1/S transition, CDC-48/p97 has been linked to 
DNA replication in several studies. The first hint for a role of CDC-48 in S phase 
progression of mitotic cells was found by Mouysset and colleagues (Mouysset et al, 
2008). In Caenorhabditis elegans, inactivation of the CDC-48UFD-1/NPL-4 complex caused 
hypersensitivity toward replication blocking agents, a reduced DNA synthesis, and a 
replication checkpoint-dependent delay in S phase progression. 
In 2011, two independent studies revealed that p97 regulates DNA replication by 
degradation of the replication licensing factor CDT1 (Franz et al, 2011; Raman et al, 
2011). The recruitment of CDT1 to origins of replication during G1 phase by the multi-
subunit origin recognition complex is a critical step in the initiation of DNA replication. 
CDT1 licenses origins by recruiting the Mcm2-7 helicase which unwinds double-
stranded DNA at the beginning of S phase (Arias & Walter, 2007).  
Upon initiation of replication in S phase, CDT1 is degraded to prevent re-firing of 
licensed origins (Arias & Walter, 2007). The E3 ubiquitin ligase CUL4-DDB1CDT2 is 
thought to be the primary E3 ligase that ubiquitylates PCNA-bound CDT1 before it is 
targeted to the proteasome for degradation (Zhong et al, 2003; Hu et al, 2004; Havens 
& Walter, 2009). In Caenorhabditis elegans, CDC-48 was found to be responsible for 
CDT-1 degradation after initiation of DNA replication, as well as for the release of the 
essential replication factors CDC-45 and the GINS complex (Franz et al, 2011). As part 
of the active replisome, CDC-45 and GINS move with the replication fork during the 
elongation step of DNA synthesis (Gambus et al, 2006; Moyer et al, 2006; Pacek et al, 
2006; Aparicio et al, 2009). A lack of CDC-48 or its cofactors UFD-1/NPL-4 leads to 
accumulation of CDT-1 on mitotic chromatin and subsequently to persistent chromatin 
association of CDC-45/GINS in Caenorhabditis elegans embryos. Furthermore, p97 
together with its cofactor UFD1 was identified as a key player of DNA damage-
dependent CDT1 destruction in HeLa cells in a genome-wide siRNA screen (Raman et 
al, 2011). After UV irradiation, the E3 ubiquitin ligase CUL4-DDB1CDT2 ubiquitinates 
PCNA-bound CDT1, before p97UFD1 unfolds and removes it from chromatin in an ATP-
dependent manner and targets it to the proteasome for degradation. Other studies link 
the role of Cdc48 in the release of CDC45 and GINS from replication forks to the 
termination of DNA replication (Maric et al, 2014; Moreno et al, 2014). When replication 
is completed, a subunit of the Mcm2-7 helicase, Mcm7, is polyubiquitylated with K48-
linked ubiquitin chains. It was shown that Mcm7 ubiquitylation is mediated by a SCF 
ubiquitin ligase, with Dia2 as the F-box protein in budding yeast (Maric et al, 2014; 
Maculins et al, 2015). SCFDia2 consists of the cullin scaffold protein Cdc53, the RING 
protein Hrt1, the adaptor protein Skp1 and the substrate recognition F-box protein 
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Dia2. In higher eukaryotes, the ubiquitin ligase targeting Mcm7 has not been identified 
so far, since Dia2 does not have a sequence homolog in higher eukaryotes. However, 
Mcm7 polyubiquitylation with K48-linked chains is followed by disassembly and release 
of the CMG complex from DNA dependent on Cdc48 (Maric et al, 2014; Moreno et al, 
2014). Intriguingly, proteasome inhibition did not stall CMG disassembly despite the 
well-known role of K48-linked ubiquitin chains as a marker for degradation of the 
modified substrate by the proteasome system. It has been proposed that Cdc48 
associates with polyubiquitylated Mcm7 and removes it from the CMG complex without 
targeting it for proteasomal degradation. By removal of Mcm7, the hexameric Mcm2-7 
ring is opened, providing an exit for DNA. Although Mcm7 does not interact with 
CDC45 or GINS, Maric and colleagues show that associations between multiple Mcm2-
7 subunits are disrupted during CMG release, presumably resulting in the release of 
CDC45 and GINS. It remains unclear how elongating replisomes are distinguished 
from terminated replisomes, since an inactive replisome is not sufficient for Mcm7 
ubiquitylation. 
Recently, it was reported that replication fork progression is coordinated by the p97 
cofactor UBXN-3 in Caenorhabditis elegans and FAS-associated factor 1 (FAF1) in 
humans, respectively (Franz et al, 2016). It was shown that UBXN-3/FAF1 binds to 
CDT-1 and additional ubiquitylated proteins, thereby recruiting CDC-48/p97 for 
turnover and disassembly of DNA replication factor complexes. Consequently, 
inactivation of UBXN-3/FAF1 stabilized CDT-1 and CDC-45/GINS on chromatin, which 
led to replication stress. This replication stress provoked a pronounced decrease in 
replication fork velocity, an increased number of stalled forks, and newly fired origins, 
finally resulting in genotoxic DNA breaks and thus, genome instability. The replication 
checkpoint was activated and DNA repair foci were formed. 
In addition to its role in replication initiation and termination, p97 probably regulates 
further steps during DNA synthesis, since it directly interacts with several replicative 
helicases including the Werner protein and HIM-6 (Bloom helicase homolog; Partridge 
et al, 2003; Indig et al, 2004; Caruso et al, 2008). 
 
1.4.4 p97 in transcription 
Like mitosis, G1/S transition, and DNA replication, DNA transcription requires p97 
activity. In the budding yeast Saccharomyces cerevisiae, the transcriptional repressor 
MATα2 is crucial for the regulation of mating type-specific gene expression. While 
ubiquitin-dependent turnover of MATα2 is responsible for the switch to the α-mating 
type (Laney, 2003), instant derepression of target genes also requires acute removal of 
the MATα2 repressor from promoters. MATα2 is ubiquitylated by Doa3 and Slx8 (Xie et 
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al, 2010), before it is turned over with the help of Cdc48Ufd1-Npl4 (Wilcox & Laney, 2009). 
Although free MATα2 is rapidly degraded by the proteasome, the ubiquitin-dependent 
extraction of MATα2 was independent of protein stability. This indicates that chromatin 
eviction and degradation of MATα2 are independent processes (Wilcox & Laney, 
2009). 
Moreover, in yeast Cdc48 mediates the dissociation of Spt23p into two forms, p90 and 
p120, and allows the ubiquitylated p90 to translocate into the nucleus and act as a 
transcription factor inducing gene expression (Rape et al, 2001). 
In Caenorhabditis elegans, CDC-48 cooperates with the ubiquitin ligase CUL-2 to 
regulate levels of the transcription factor TRA-1 and thereby controls sex determination 
(Sasagawa et al, 2009). 
 
1.4.5 p97 and its cofactors in the DNA damage response 
Cells are constantly exposed to a multitude of genotoxic insults, including 
environmental factors like UV light or ionizing radiation (IR) and endogenous metabolic 
products such as formaldehyde which can cause DNA damage. DNA damage, if 
unrepaired, can lead to mutagenesis and genome instability, and thus contribute to 
tumorigenesis and aging. To encounter this problem, cells have evolved diverse DNA 
repair and DNA damage tolerance pathways that are activated in the DDR (Nyberg et 
al, 2002; Jackson & Bartek, 2009). The choice between these pathways depends on 
the type of lesion and the cell cycle stage. Over the last decade, p97 has been linked to 
many of these pathways. Notably, upon DNA damage, p97 is phosphorylated at S784 
by DNA-PK and accumulates at sites of DNA lesion (Livingstone et al, 2005). 
 
1.4.5.1 DNA damage during DNA replication – translesion synthesis and 
template switch 
Since cells are constantly exposed to genomic stress, they also must attempt to 
replicate damaged DNA. During S phase, secondary DNA structures, DNA-protein 
complexes or damaged bases can impede DNA replication. To ensure faithful 
replication in the presence of DNA damage, cells activate an intra S phase checkpoint 
to slow down replication (Branzei & Foiani, 2010). When replication forks encounter 
DNA lesions, they stall because the high-fidelity polymerases cannot accommodate 
damaged bases in their active sites. This can potentially lead to fork collapse, giving 
rise to highly cytotoxic DSBs. To cope with this issue, cells have evolved strategies to 
bypass replication-blocking lesions. Either, the lesions can be bypassed by specialized 
DNA polymerases in a process called translesion synthesis (TLS; Sale et al, 2012), or 
the cell uses the complementary strand and makes a template switch. The decision 
Introduction 
41 
 
between these two pathways is triggered by ubiquitylation of PCNA. Monoubiquitylation 
at K164 by the ubiquitin ligase RAD6/RAD18 leads to TLS (Friedberg et al, 2005), 
while polyubiquitylation with K63-linked ubiquitin chains results in a template switch. 
When PCNA is monoubiquitylated, it recruits TLS polymerases via interactions with 
their ubiquitin-binding domains, followed by a polymerase switch at the lesion. Many 
TLS polymerases belong to the Y family, characterized by large active sites that 
accommodate distorted bases or bulky DNA lesions (Prakash et al, 2005). These 
polymerases are Polη, Polι, Polκ and Rev1. TLS across moderate lesions like UV-
induced cyclobutane pyrimidine dimers (CPDs) is established by Polη. Bulkier adducts 
such as UV-induced 6-4photoproducts (6-4PPs) require the activity of at least two TLS 
polymerases. While a member of the Y family polymerases inserts nucleotides 
opposite of the lesion, the B family member Polζ carries out an extension step 
(Prakash, 2002; Livneh et al, 2010; Sale et al, 2012). Due to the low fidelity of TLS 
polymerases, TLS is a potentially error-prone process and bears an intrinsic mutagenic 
nature (Kunz et al, 2000). Thus, ideally, TLS polymerase activity has to be restricted to 
sites of DNA damage. After lesion bypass, PCNA is deubiquitylated by the ubiquitin 
specific peptidase USP1 (Huang et al, 2006). This induces the switch from translesion 
back to replicative polymerases and continuation of DNA replication (Fox et al, 2011).  
Recently, the p97 adaptor protein DVC1 has been identified as a central factor in TLS 
(Centore et al, 2012; Davis et al, 2012; Ghosal et al, 2012; Juhasz et al, 2012; Machida 
et al, 2012; Mosbech et al, 2012; Kim et al, 2013). DVC1 can bind ubiquitin via an 
UBZ4-type domain and it can interact with PCNA via a PIP box (Centore et al, 2012; 
Davis et al, 2012; Ghosal et al, 2012; Juhasz et al, 2012; Machida et al, 2012; 
Mosbech et al, 2012). While some studies suggest that DVC1 recruitment to stalled 
replication forks requires RAD18-mediated monoubiquitylation of PCNA (Centore et al, 
2012; Ghosal et al, 2012; Juhasz et al, 2012; Machida et al, 2012), two other studies 
report that DVC1 recruitment is independent of RAD18 (Davis et al, 2012; Mosbech et 
al, 2012). Moreover, one group claims that DVC1 promotes a feed-forward loop to 
enhance PCNA ubiquitylation and TLS (Centore et al, 2012), whereas according to 
another group, DVC1 protects ubiquitylated PCNA from deubiquitylation by USP1 and 
hence supports TLS (Juhasz et al, 2012). Yet another study suggests that DVC1 
negatively influences TLS dependent on POLD3, which is the accessory subunit of the 
replicative Polδ. By interaction of its SprT domain with POLD3, DVC1 inhibits the 
extension step of Rev1/Polζ-dependent error-prone TLS (Kim et al, 2013). Apart from 
its UBZ domain and its PIP box, DVC1 contains a SHP box, with which it recruits p97 
to stalled replication forks (Davis et al, 2012; Ghosal et al, 2012; Mosbech et al, 2012). 
Ghosal and colleagues propose that DVC1 prevents removal of RAD18 and 
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monoubiquitylated PCNA from chromatin by p97 (Ghosal et al, 2012). Furthermore, 
they and another independent group suggest that DVC1 removes the replicative Polδ 
at UV lesions to allow recruitment of Polη (Ghosal et al, 2012; Juhasz et al, 2012). 
Conversely, two studies claim that DVC1 recruits p97 to stalled replication forks to 
extract Polη and allow the switch to replicative polymerases after bypassing the UV 
lesion (Davis et al, 2012; Mosbech et al, 2012). Moreover, it is under debate whether 
the p97 cofactors Ufd1 and Npl4 are involved in TLS (Davis et al, 2012) or not 
(Mosbech et al, 2012). In summary, there is controversy, if DVC1 positively regulates 
TLS (Centore et al, 2012; Ghosal et al, 2012; Juhasz et al, 2012; Machida et al, 2012) 
or if it prevents excessive TLS and limits the incidence of mutations induced by DNA 
damage (Davis et al, 2012; Mosbech et al, 2012; Kim et al, 2013). 
 
1.4.5.2 p97 in nucleotide excision repair 
UV-induced DNA lesions like CPDs and 6-4PPs are removed by NER to preserve 
genome integrity. NER is subdivided in transcription-coupled NER (TC-NER), which 
selectively removes UV lesions from actively transcribed genes, and global genome 
NER (GG-NER). When RNA polymerase II complexes stall at photolesions during 
transcription, they are displaced to make the lesion accessible to NER proteins. 
Following its displacement, the largest subunit of RNA polymerase II, Rpb1, is 
degraded by the proteasome in a ubiquitin-dependent manner (Wilson et al, 2013). In 
yeast, Rpb1 ubiquitylation is mediated by the HECT ubiquitin ligase Rsp5 and the 
CUL3-based CRL3ELC1 complex. After K63-linked polyubiquitylation of Rpb1 catalyzed 
by Rsp5 (Huibregtse et al, 1997; Kim & Huibregtse, 2009), the DUB Ubp2 trims these 
chains to single ubiquitin moieties, before CRL3ELC1 extends these single ubiquitin 
moieties to K48-linked ubiquitin chains required for Rpb1 degradation (Harreman et al, 
2009). In contrast, in human cells the Rsp5-related NEDD4 governs UV-induced 
turnover of Rpb1 (Anindya et al, 2007; Harreman et al, 2009). A study in budding yeast 
demonstrated that Cdc48Ufd1-Npl4 is required for degradation of Rpb1 after UV treatment 
(Verma et al, 2011). In addition to the ubiquitin adapter Ufd1-Npl4, this process 
requires the less well-characterized Cdc48 adapters Ubx4 (UBXD9 in humans) and 
Ubx5 (UBXD7 in humans).  
In addition to Rpb1 degradation, p97 mediates the degradation of CSB, which is 
required for the proteolytic release of RNA polymerase II (Bregman et al, 1996; 
Svejstrup, 2002; Anindya et al, 2007). CSB has a translocase (DNA-dependent 
ATPase) activity which is able to remodel the interface between RNA polymerase II 
and damaged DNA to allow repair to take place (Citterio, 1998; Citterio et al, 2000; 
Svejstrup, 2002; Cho et al, 2013). CSB undergoes proteasomal degradation after 
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ubiquitylation by the CUL4A-DDB1CSA E3 ligase (Groisman, 2006). It has been shown 
that p97, Ufd1, and UBXD7 are involved in CSB turnover (He et al, 2016). The 
degradation of CSB is suggested as a prerequisite for post-TC-NER recovery of RNA 
synthesis. It is conceivable that the timely removal of lesion-arrested RNA polymerase 
II or CSB from lesion sites promotes the productive sequential assembly of the pre-
incision complex. 
Independently of transcription, the DNA damage sensor proteins DDB2 and XPC 
recognize UV lesions and induce the GG-NER pathway (de Laat et al, 1999). While 
XPC detects various helix-distorting photoproducts and DNA adducts, DDB2 is 
specialized on the recognition of UV-induced CPDs and 6-4PPs (Hwang et al, 1999; 
Wakasugi et al, 2002; Wittschieben, 2005; Fischer et al, 2011; Yeh et al, 2012). 
Interestingly, DDB2 is part of a CUL4A-DDB1 ubiquitin ligase complex which is 
recruited to DNA lesions by DDB2 (Scrima et al, 2008). This ubiquitin ligase complex 
catalyzes ubiquitylation of DDB2 itself, leading to its proteasomal degradation, and of 
the second DNA lesion sensor XPC, which has been proposed to enhance its binding 
to DNA (Sugasawa et al, 2005). Then, p97 is recruited to UV lesions in a ubiquitin- and 
DDB2-dependent manner and helps to remove chromatin extraction of DDB2 and XPC 
(Puumalainen et al, 2014). For DDB2 removal, it was shown that p97 acts together with 
Ufd1-Npl4 and UBXD7. Prolonged chromatin retention of DDB2 and XPC results in 
impaired DNA repair of UV lesions and compromised genome integrity. 
Following damage recognition, about 25-30 nucleotides around the lesion site of the 
damaged strand are excised by structure-specific endonucleases. The resulting gap is 
filled by DNA polymerization dependent on PCNA and CUL4ADDB2. Like in normal DNA 
replication, CDT1 binds to PCNA to initiate gap-filling DNA synthesis. Upon initiation, 
CDT1 is polyubiquitylated by CUL4-DDB1DDB2-CDT2, segregated from chromatin by 
p97Ufd1-Npl4 and degraded by the proteasome (Nishitani et al, 2006; Raman et al, 2011; 
Ramanathan & Ye, 2011). 
 
1.4.5.3 p97 in the Fanconi anemia DNA repair pathway 
DNA interstrand crosslinks are an obstacle to ongoing DNA replication and 
transcription machineries (Kim & D'Andrea, 2012; Kottemann & Smogorzewska, 2013). 
In order to repair interstrand crosslinks, cells activate the Fanconi anemia (FA) DNA 
repair pathway. The key player of this repair pathway, which relies on the programmed 
formation of a DSB, is the FANCI/FANCD2 complex (ID complex). ATM/ATR kinases 
phosphorylate FANCI, which is suggested to stabilize the interaction between FANCD2 
and FANCI (Ishiai et al, 2008; Joo et al, 2011). Subsequently, FANCD2 is 
monoubiquitylated at K561 and FANCI on K523 by the FA core complex, a large 
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multisubunit ubiquitin ligase (Kim & D'Andrea, 2012). Upon ubiquitylation, nucleases 
like XPF/ERCC1 are recruited to the ID complex, which then incise the DNA in 
proximity to the interstrand crosslink to cut out the crosslink with the concomitant 
formation of a DSB (Knipscheer et al, 2009; Hodskinson et al, 2014; Klein Douwel et al, 
2014). Monoubiquitylation of the ID complex is antagonized by the DUB complex 
USP1-UAF1 (Cohn et al, 2007). In addition to phosphorylation and monoubiquitylation, 
the tumor suppressors FANCI and FANCD2 are sumoylated by the SUMO E3 ligases 
PIAS1/PIAS4 upon replication fork stalling (Gibbs-Seymour et al, 2015). This 
sumoylation is antagonized by the SUMO protease SENP6. Sumoylation of the ID 
complex, in turn, triggers its polyubiquitylation by the SUMO-targeted ubiquitin ligase 
RNF4, thereby promoting its dissociation from sites of DNA damage through the 
p97DVC1 ubiquitin segregase complex (Gibbs-Seymour et al, 2015). The FA pathway 
uses translesion synthesis, homologous recombination, and nucleotide excision repair 
to complete the repair process (Knipscheer et al, 2009; Zhang & Walter, 2014). 
 
1.4.5.4 p97 in DSB repair 
The most deleterious type of DNA lesion is the DSB. If not repaired, it can lead to 
chromosomal rearrangements, deletions and genome instability or even cell death. It is 
estimated that approximately 1% of single-strand breaks are converted to DSBs in 
human cells per cell cycle, which yields about 50 endogenous DSBs (Vilenchik & 
Knudson, 2011). This number resembles the number of DSBs induced by 1.5-2.0 Gy of 
IR. 
After DNA damage, the histones H2A and H2AX are ubiquitylated at sites of DSBs 
(Bekker-Jensen & Mailand, 2011). The two ubiquitin ligases RNF8 and RNF168 have 
emerged to catalyze ubiquitin chain formation at sites of DNA damage. Together, they 
assemble K63 ubiquitin chains, while RNF8 alone forms K48 ubiquitin chains. RNF8 
recruits proteasomes to DNA lesions (Galanty et al, 2012) and targets chromatin-
associated proteins for proteasomal degradation. The histones H2A and H2AX are 
modified by K63 ubiquitin chains at K13-15 (Mattiroli et al, 2012). Subsequently, p97 is 
recruited to RNF8/K48 ubiquitin conjugates via its ubiquitin adapter Ufd1-Npl4 and 
removes them to orchestrate proper association of the DDR proteins BRCA1, Rad51, 
and 53BP1 (Meerang et al, 2011). Thus, p97-dependent degradation of K48 
ubiquitylated proteins is critical for activation of the DDR (Ramadan, 2012). Impairment 
of p97 activity reduces the main branches of DSB repair, homologous recombination 
(HR) and non-homologous end-joining (NHEJ), and decreases cell survival after IR 
(Meerang et al, 2011). However, the specific p97 substrates at DSB sites as well as the 
mechanisms by which p97 influences DSB repair remain unknown. 
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In contrast to RAD18 and the BRCA1/RAP80 complex, 53BP1 directly interacts with a 
dimethyl mark at K20 of the core histone H4 (H4K20me2) at sites of DNA damage via 
its tandem Tudor domain (Botuyan et al, 2006). In undamaged chromatin, the same 
mark is bound by the second malignant brain tumor (MBT) domain of the tumor 
suppressor L3MBTL1 (Min et al, 2007). Upon DNA damage in form of DSBs, L3MBTL1 
is removed from chromatin by the ubiquitin ligases RNF8/RNF168 and the segregase 
p97Ufd1-Npl4 (Acs et al, 2011). Release of L3MBTL1 from H4K20me2 at DSBs then allows 
binding of 53BP1 to the newly exposed histone methyl marks. Recently, it was shown 
that 53BP1 additionally binds to the ubiquitylated lysine residue 15 of histone H2A 
(H2AK15ub; Fradet-Turcotte et al, 2013), of which ubiquitylation is catalyzed in 
response to DNA damage by RNF168 (Mattiroli et al, 2012). Thus, 53BP1 recognizes 
two DNA damage-induced histone modifications by which it is recruited to DSBs. 
Another protein which associates with H4K20me2 is the histone demethylase 
JMJD2A/B, which is ubiquitylated by RNF8 before it is degraded by the proteasome 
(Mallette et al, 2012). Regarding JMJD2A/B degradation, it remains to be clarified if 
p97 is implicated. 
Repair of DSBs by HR implicates the formation of a nucleoprotein filament formed by 
the recombinase RAD51 between the sister chromatids. In Saccharomyces cerevisiae, 
loading of RAD51, which replaces RPA on single-stranded DNA, depends on DNA 
damage-induced sumoylation of its binding partner RAD52. Modification of RAD52 with 
the small ubiquitin-related modifier SUMO promotes the interaction of RAD52 with 
RAD51, which contains a SUMO-interacting motif (SIM; Bergink et al, 2013). 
Intriguingly, Cdc48 and Ufd1 in yeast also bear a SIM (Hannich et al, 2005; Nie et al, 
2012) that binds to sumoylated RAD52 resulting in destabilization of RAD51-RAD52 
interaction in vitro (Bergink et al, 2013). However, the significance of this pathway in 
mammals remains elusive. Notably, it was shown that impaired p97 function entails 
compromised RAD51 accumulation after IR concomitant with decreased HR (Meerang 
et al, 2011). Thus, p97 possibly restricts spontaneous HR by removing RAD52 from 
chromatin, while it promotes IR-induced HR through another unknown mechanism. 
 
1.5 p97-associated diseases 
The participation of p97 in a wide variety of cellular processes suggests a diverse 
involvement in disease. Indeed, p97 has been implicated in the pathogenesis of many 
human diseases, including Paget’s disease of bone, several types of 
neurodegenerative disorders, and different kinds of cancer (Vij, 2008; Haines, 2010). 
Inclusion body myopathy associated with Paget’s disease of bone and frontotemporal 
dementia (IBMPFD) has been directly associated with p97 dysfunction (Kimonis et al, 
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2008). IBMPFD is an autosomal dominant negative inherited degenerative disorder 
caused by a missense mutation in p97 (Watts et al, 2004). Patients suffering from 
IBMPFD have different p97 mutations that are all primarily located at the interface of 
the N and the D1 domain (Weihl et al, 2009). The most frequent mutation is the 
exchange of arginine at position 155 for histidine (R155H; Hubbers et al, 2007). 
IBMPFD is characterized by disabling weakness, osteolytic lesions consistent with 
Paget’s disease of bone and frontotemporal dementia. In tissues of patients with 
IBMPFD, cytoplasmic and nuclear ubiquitin-positive aggregates are accumulated. 
There is evidence that defective p97 functioning in lysosomal degradation is the 
primary cause of IBMPFD (Ju et al, 2009; Ju & Weihl, 2010; Tresse et al, 2010; Bug & 
Meyer, 2012). 
Additionally, p97 mutations have been linked to 2% of isolated familial amyotrophic 
lateral sclerosis (ALS; Johnson et al, 2010). 
Furthermore, dysfunctional p97 was found in cells expressing numerous polyglutamine 
proteins which give rise to neurodegenerative diseases like Huntington’s disease, 
spinal and bulbar muscular atrophy and several inheritable spinocerebellar ataxias (La 
Spada & Taylor, 2010). Recently, a study connected DNA repair defects to 
polyglutamine diseases. This study revealed that the p97-mediated extraction of 
L3MBTL1 at DNA lesions was impaired in cellular as well as fly models of multiple 
polyglutamine diseases (Fujita et al, 2013). 
Despite the crucial role of p97 for genomic maintenance (Cheng & Chen, 2010; 
Dobrynin et al, 2011; Riemer et al, 2014) and for modulation of various oncogenes and 
tumor suppressors (e.g. HIF1α, p53, IκBα, NF-κB, BRCA1), so far, there is no direct 
proof that mutations in p97 are related to cancer. Yet, p97 expression levels were 
found to be altered in cancer patients. Thereby, increased levels of p97 correlated with 
the progression, prognosis, and metastatic potential of many cancers (Chapman et al, 
2015). Patients with tumors that express high levels of p97 display a higher recurrence 
rate, poorer disease-free periods and overall survival. Tumors, where elevated p97 
levels have been observed, include colorectal carcinoma, pancreatic cancer, thyroid 
cancer, breast cancer, squamous cell carcinoma, gastric carcinoma, osteosarcoma, 
liver, ovary, and lung cancer. In contrast, low p97 expression levels have been found in 
adenomas. It remains unclear, if higher p97 levels are responsible for the turnover of 
growth inhibitory proteins or if elevated p97 expression is the result of protein-induced 
stress in cancer (Haines, 2010). 
Not only p97 itself, but also a few of its cofactors have been linked to cancer. For 
example, haploinsufficiency of the FAF1 gene, which belongs to the UBX family of p97 
adaptor proteins, was found in 30% of cervical carcinomas and 12.5% of mantle-cell 
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lymphomas (Hidalgo et al, 2005; Bea et al, 2009). Moreover, FAF1 protein levels are 
decreased in gastric carcinomas and a large percentage of mesotheliomas (Bjørling-
Poulsen et al, 2003; Altomare et al, 2009). Recently, a homozygotic mutation in the p97 
adaptor DVC1 has been associated with genome instability, premature ageing and 
cancer predisposition both in humans (Lessel et al, 2014) and in mice (Maskey et al, 
2014). 
While the neurodegenerative diseases associated with dysfunctional p97 would require 
restoration of p97 function for cure, cancers with increased p97 levels could be treated 
with p97 inhibition. Indeed, tumor growth of non-small cell lung carcinoma was 
significantly reduced in vitro and in vivo by inhibition of p97 with the small molecule 
Eeyarestatin I (Valle et al, 2011). Additionally, there is a direct link between p97 and 
the levels of p53 and NF-κB, two transcription factors involved in cancer cell survival 
(Valle et al, 2011). This suggests that elevated p97 levels may be directly responsible 
for tumorigenesis. There is growing evidence that tumor cells are susceptible to p97 
inhibition (Valle et al, 2011; Chou et al, 2011; Chou et al, 2013; Magnaghi et al, 2013; 
Cervi et al, 2014; Anderson et al, 2015; Zhou et al, 2015; Parzych et al, 2015; Nadeau 
et al, 2015). 
 
1.6 p97 inhibitors 
Currently, the only established drugs targeting protein quality control used in the clinics 
are proteasome inhibitors like bortezomib or carfilzomib that are applied to treat 
multiple myeloma and lymphoma (Jain et al, 2011; Goldberg, 2012). It has been 
proposed that these drugs mainly affect the secretory pathway and thus, are effective 
against blood cancers that derive from cells producing large numbers of secretory 
proteins. The success of bortezomib and carfilzomib proves that targeting protein 
quality control is a viable treatment option. However, the search for other targets in the 
protein quality control pathway was expanded to achieve enhanced cancer cell 
specificity, increased clinical utility, a lower resistance rate, decreased toxicity, and 
mitigated site effects. Over the last decade, p97 has evolved as a promising target 
since it is involved in ERAD, activates pro-survival transcription factors, is implicated in 
autophagy and regulates the cell cycle, all of which are proven to be critical in cancer 
therapy (Braun & Zischka, 2008; Haines, 2010; Chapman et al, 2011; Choi et al, 2013). 
In 2004, the first p97 inhibitor eeyarestatin I (EerI) was identified (Fiebiger, 2004). EerI 
was shown to inhibit ERAD (Wang et al, 2008; Wang et al, 2010) and to work in 
concert with bortezomib in inducing ER-stress-mediated apoptosis in cancer cells 
(Wang et al, 2009; Auner et al, 2013). Recently, it was demonstrated that EerI induces 
DNA damage rather than ER stress and that it selectively kills canine lymphoma cells 
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(Nadeau et al, 2015). However, EerI suffers from irreversibility, and low potency (Wang 
et al, 2008; Wang et al, 2010). 
The first reversible, selective small molecule p97 inhibitor was discovered in 2011 
(Chou et al, 2011). N2, N4-dibenzylquinazoline-2,4-diamine (DBeQ) efficiently blocks 
p97-dependent processes, including autophagy and proteasome-mediated degradation 
of ubiquitin fusion degradation and ERAD substrates (Chou et al, 2011). Moreover, 
DBeQ rapidly activates apoptotic cell death and inhibits cancer cell growth (Chou et al, 
2011; Chou & Deshaies, 2011). Further studies revealed that DBeQ binds to the D1 
and the D2 domain of p97 (Chou et al, 2014). 
In 2013, alkylsulfanyl-1,2,4-triazoles were identified as a new class of p97 inhibitors 
with sub-micromolar IC50 values (Polucci et al, 2013). Among these alkylsulfanyl-1,2,4-
triazoles that affect p97 were the covalent inhibitor NMS-859 and the allosteric inhibitor 
NMS-873 (Magnaghi et al, 2013). NMS-859 binds to C522 in the D2 ATP binding 
pocket (Magnaghi et al, 2013). In contrast, the allosteric inhibitor NMS-873 targets the 
D2 Walker B motif and prevents ADP-release from the D1 and the D2 domain 
(Magnaghi et al, 2013; Burrell et al, 2013; Chou et al, 2014). Both molecules caused an 
accumulation of ubiquitylated proteins, induced the unfolded protein response due to 
ER stress, compromised autophagy, and induced apoptosis in HCT116 cells 
(Magnaghi et al, 2013). In addition, they led to a cell cycle arrest in G2 in HCT116 cells 
(Magnaghi et al, 2013). The effect of NMS-873 was compared to the effect of 
bortezomib in 37 cancer cell lines (Magnaghi et al, 2013). It was observed that specific 
cell lines were differentially sensitive to the two inhibitors, arguing for a therapeutic use 
of p97 inhibitors in the treatment of diverse cancers, not only of blood cancers as in the 
case of bortezomib. Furthermore, it was demonstrated that the presence of the p97 
cofactor p47, which inhibits p97 ATPase activity, increased the IC50 of NMS-873 
(Chou et al, 2014). Altogether, these studies confirmed NMS-873 as a potent, highly 
specific p97 inhibitor. 
Recently, the potent, ATP-competitive, D2-selective, and orally bioavailable p97 
inhibitor CB-5083, which is a derivative of DBeQ, has been taken into phase 1 clinical 
trials in patients with multiple myeloma and solid tumors (Anderson et al, 2015; Zhou et 
al, 2015). 
 
1.7 Aims of the thesis 
At the start of this thesis, accumulating evidence from different organisms suggested 
that p97 was not only involved in mitosis, but also in the DNA damage response and 
replication stress responses in interphase. The aim of this thesis was therefore to 
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explore possible mechanisms and the relevance of these roles in human cells. To do 
so, this study concentrated on three major aspects. 
The first aim was to clarify a possible implication of p97 in DNA damage checkpoints. 
Thereby, this study contributes to understanding the function of the p97Ufd1-Npl4 complex 
in the G2/M checkpoint, facilitating the degradation of CDC25A (published in Riemer et 
al., 2014). 
Second, we analyzed the significance of p97 and its cofactors for survival of human 
cancer cells after replication stress. This included an investigation of possible 
synergistic effects of novel p97 inhibitors with genotoxic chemotherapeutic agents and 
their influence on the DNA damage response. 
Third, we explored the role of the novel p97 cofactor UBXD7 that was recently linked to 
DNA repair. For this purpose, we examined the relevance of UBXD7 for diverse p97 
substrate proteins including CDC25A and a detailed structure-function analysis of 
UBXD7 to investigate its functional relationship to p97. 
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2 Results 
2.1 The role of p97 for the G1/S and intra S checkpoints 
Recently, our laboratory has shown that p97Ufd1-Npl4 is required for the activation of the 
G2/M checkpoint by facilitating the degradation of the phosphatase CDC25A (Riemer 
et al, 2014). CDC25A is responsible for removing inhibitory phosphates from CDKs, 
leading to their activation and thus cell cycle progression. Hence, inactivation of 
CDC25A by degradation leads to a cell cycle arrest. As part of the study published in 
Riemer et al, 2014, we raised the question if p97Ufd1-Npl4 helps to degrade CDC25A only 
in the G2/M checkpoint, or additionally in the G1/S checkpoint and the intra S 
checkpoint, since CDC25A is involved in G1/S transition, S phase progression and 
G2/M transition. 
 
2.1.1 No effect of Ufd1-Npl4 depletion on the G1/S checkpoint 
To explore the importance of p97 and its cofactors for the G1/S checkpoint, a dual-
color flow cytometric analysis with 5-bromo-2’-deoxyuridine (BrdU) and the DNA-
binding dye propidium iodide (PI) was performed (Xu & Kastan, 2004). BrdU is a 
synthetic nucleoside which is incorporated into newly synthesized DNA of replicating 
cells in place of its analog thymidine. BrdU incorporation can then be detected with 
specific antibodies, highlighting cells that were undergoing DNA replication. 
Counterstaining with PI shows the cell cycle. 
In our setting, HeLa cells were depleted of p97, Ufd1, or Npl4 with small interfering 
RNAs (siRNAs) for 48 h and irradiated with 6 Gy to activate DNA damage checkpoints. 
An siRNA targeting luciferase (siluc) served as a negative control, whereas 
downregulation of the checkpoint kinase Chk1 was supposed to inhibit the checkpoint. 
The cells were pulse-labeled with 10 µM BrdU for 30 min 24 h post irradiation and then 
harvested and fixed with 80% ethanol. To allow antibody binding, DNA was denatured 
by acid treatment with hydrochloric acid. Finally, staining of anti-BrdU antibody and PI 
were detected by flow cytometry. 
Data analysis revealed that mock-depleted cells showed a marked decrease in DNA 
synthesis after irradiation, indicated by reduced BrdU incorporation (Fig. 2.1 and 2.2). 
In contrast, knockdown of Chk1 resulted in an override of the checkpoint, since 
irradiation did not affect the percentage of BrdU-positive cells. Depletion of Ufd1 or 
Npl4 displayed a decrease in DNA synthesis after irradiation, indicating a functional 
G1/S checkpoint. Intriguingly, knockdown of p97 significantly reduced the percentage 
of BrdU-incorporating cells in non-irradiated cells. Moreover, this drop in replicating 
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cells was not further reduced upon irradiation. Notably, none of the depletions led to a 
major change in cell cycle distribution (Fig. 2.1). 
 
Figure 2.1: Representative dot plots and histograms of siRNA-treated cells for analysis of 
the G1/S checkpoint. HeLa cells were mock-transfected with siluc or with siRNAs targeting 
Chk1, p97, Ufd1, or Npl4 for 48 h. The cells were irradiated with 6 Gy and fixed 24 h later. Prior 
to fixation, the cells were pulse-labeled with BrdU for 30 min. Samples were co-stained with an 
anti-BrdU antibody and the DNA-binding dye propidium iodide (PI), before they were analyzed 
by flow cytometry. The BrdU-positive cells are highlighted in red. Histograms show no major 
impact on the cell cycle upon depletion of the indicated proteins. 
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Figure 2.2: Ufd1-Npl4 depletion does not affect the G1/S checkpoint. Quantification of 
BrdU-positive cells in an analysis of the G1/S checkpoint. HeLa cells were depleted of the 
indicated proteins for 48 h. The cells were irradiated with 6 Gy and fixed 24 h later. Prior to 
fixation, the cells were pulse-labeled with BrdU for 30 min. The staining with an anti-BrdU 
antibody was detected by flow cytometry. Shown are means of three to four independent 
experiments and error bars represent s.d. * p < 0.05. 
 
Taken together, these data show that Ufd1-Npl4 depletion has no effect on the G1/S 
checkpoint. However, p97 seems to be important for DNA replication. 
 
2.1.2 βTrCP and DVC1 are important for the intra S checkpoint 
To investigate if p97 participates in the intra S checkpoint, a replication assay 
(radioresistant DNA synthesis, shortly RDS) was applied (Xu & Kastan, 2004). Similar 
to the BrdU assay, the RDS assay is based on the incorporation of radioactively 
labeled thymidine into newly synthesized DNA. Since DVC1 was shown to be involved 
in TLS, we included this p97 adaptor in our setting. 
HeLa cells were mock-transfected with siluc or transfected with siβTrCP, sip97, siNpl4, 
siUfd1, or siDVC1 for 48 h. Knockdown of βTrCP served as a positive control, as its 
downregulation by RNA interference (RNAi) was already demonstrated to result in a 
defective intra S checkpoint and RDS due to stabilization of CDC25A phosphatase 
(Busino et al, 2003). The cells were irradiated with 10 Gy and fixed with ethanol after 
15 min, 1 h, and 4 h, respectively. Before fixation, the cells were pulse-labeled for 
15 min with 3H-thymidine. Incorporation of 3H-thymidine was quantified by a scintillation 
counter. 
In general, 1 h after irradiation, the cells showed a decrease in DNA synthesis, from 
which they recovered 4 h after irradiation (Fig. 2.3A to D). Cells depleted of βTrCP or 
DVC1 showed a significant increase in RDS 1 h after irradiation compared to control-
depleted cells (Fig. 2.3E). In contrast, knockdown of p97, or its cofactors Npl4 or Ufd1 
only displayed a minor increase in RDS. However, DVC1 and again p97 depletion led 
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to a significant decrease in DNA synthesis in non-irradiated cells, respectively (Fig. 
2.4). 
 
 
Figure 2.3: Knockdown of βTrCP and DVC1 leads to radioresistant DNA synthesis. (A, B, 
C, D) The kinetics of radioresistant DNA synthesis in depleted cells. HeLa cells were mock-
transfected with siluc or with siRNAs targeting βTrCP, p97, Ufd1, Npl4, or DVC1 for 48 h. The 
cells were irradiated with 10 Gy and fixed after 15 min, 1 h, and 4 h, respectively. Prior to 
fixation, the cells were pulse-labeled for 15 min with 
3
H-thymidine. 
3
H-thymidine was then 
detected by a scintillation counter. Shown are means of three to five independent experiments 
and error bars represent s.d. * p < 0.05. DNA synthesis levels without IR were set to 100% for 
each depletion. (E) Remaining DNA synthesis 1 h after 10 Gy IR. Data are taken from subfigure 
A to D. 
 
Together, these data show that p97 and DVC1 are essential for efficient DNA 
replication and that DVC1 has a role in the intra S checkpoint. 
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Figure 2.4: Knockdown of p97 leads to a significant reduction in DNA synthesis in non-
irradiated cells. HeLa cells were transfected with the indicated siRNAs for 48 h and pulse-
labeled for 15 min with 
3
H-thymidine. 
3
H-thymidine was then detected by a scintillation counter. 
Shown are means of three to five independent experiments and error bars represent s.d. 
* p < 0.05. 
 
2.2 p97 ensures robustness of the G2/M checkpoint by facilitating 
CDC25A degradation 
Our laboratory confirmed CDC25A as the p97 target in the G2/M checkpoint by 
monitoring checkpoint signaling via immunoblot analysis (Riemer et al, 2014). Upon 
knockdown of Ufd1 or Npl4, the checkpoint kinase Chk1 was phosphorylated at S317 
and S345 after treatment with IR suggesting that it was fully activated in the response 
to DNA damage. Moreover, phosphorylation of CDC25C, which leads to its inactivation 
by sequestration in the cytoplasm, was unaffected. However, CDC25A was stabilized 
in Ufd1- as well as Npl4-depleted cells after DNA damage induction. A cycloheximide 
(CHX) chase revealed that CDC25A degradation after IR is delayed in cells lacking 
Ufd1 or Npl4, resulting in a compromised G2/M checkpoint. 
 
2.2.1 Generation and characterization of a cell line inducibly expressing GFP-
CDC25A 
As part of the study published in Riemer et al, 2014, we aimed to further analyze the 
role of p97 and its cofactors in CDC25A degradation by fluorescence microscopy. For 
this purpose, a U2OS reporter cell line expressing GFP-CDC25A under control of a 
doxycycline-inducible promoter was generated and characterized. In the first step, N-
terminally tagged GFP-CDC25A was cloned from the vector pOPINE (a gift from Dr. 
Christian Ottmann, Chemical Genomics Centre, Dortmund, Germany) into the vector 
pcDNA 5.0/FRT/TO (Invitrogen). To generate a stable cell line inducibly expressing 
GFP-CDC25A, pcDNA 5.0/FRT/TO-GFP-CDC25A was transfected together with 
pOG44 Flp-recombinase (Invitrogen) into U2OS-FRT-TO cells for integration into the 
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genome at the FRT recombination site. The Tet repressor can be removed upon 
induction with a tetracycline such as doxycycline. Expression of GFP-CDC25A was 
confirmed by fluorescence microscopy and immunoblot analysis. Fluorescence images 
show that GFP-CDC25A is expressed in the nuclei after doxycycline treatment (Fig. 
2.5A). Moreover, the GFP-CDC25A levels differ from cell to cell. Western blot analysis 
revealed that doxycycline-induced expression levels of GFP-CDC25A clearly exceed 
levels of endogenous CDC25A (Fig. 2.5B). Furthermore, induced cells show several 
GFP-CDC25A degradation products. 
 
 
Figure 2.5: A reporter cell line inducibly expressing GFP-CDC25A was generated. (A) 
Microscopy images of doxycycline (DOX)-induced GFP-CDC25A expression. GFP-CDC25A 
expression of the stably transfected U2OS cells was induced by doxycycline treatment for 24 h. 
The cells were fixed with paraformaldehyde and nuclei were stained with DAPI. GFP-CDC25A 
expression was examined by fluorescence microscopy. Scale bar: 50 µm. (B) Immunoblot of 
doxycycline-induced GFP-CDC25A expression. GFP-CDC25A expression of the U2OS reporter 
cell line was induced by doxycycline for 6 h. The cells were lysed and cell lysates were 
subjected to SDS-PAGE and Western blotting. GFP-CDC25A and endogenous CDC25A were 
detected by an anti-CDC25A antibody. GAPDH served as loading control. 
 
2.2.2 GFP-CDC25A is degraded upon IR 
Since CDC25A is degraded in the DDR, it was examined if the generated reporter cell 
line responds to IR. In order to characterize this cell line, the kinetics of GFP-CDC25A 
degradation was evaluated using fluorescence microscopy and immunoblotting (Fig. 
2.6). For fluorescence microscopy, the cells were induced with doxycycline for 24 h. 
Then, the cells were mock-irradiated or irradiated with 10 Gy and CHX was added to 
inhibit protein biosynthesis. Thus, protein turnover can be monitored after addition of 
CHX since no proteins are re-synthesized. At different time points (0, 30, or 60 min) the 
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cells were fixed with paraformaldehyde and mounted with Mowiol containing the DNA 
dye DAPI. Fluorescence microscopy showed a significant decrease in GFP intensity 
already 30 min after irradiation and CHX treatment (Fig. 2.6A and B). GFP-CDC25A 
degradation can also be followed by immunoblotting. In this approach, again GFP-
CDC25A expression was induced by doxycycline treatment for 6 h. Then, the cells 
were mock-irradiated or irradiated with 10 Gy and CHX was added. At different time 
points (0, 30, or 60 min) the cells were lysed and cell lysates were subjected to SDS-
PAGE and analyzed by Western blotting (Fig. 2.6C). In non-irradiated cells, GFP-
CDC25A was degraded within 60 min. After irradiation with 10 Gy, the rate of GFP-
CDC25A degradation was accelerated (Fig. 2.6D). This confirms that the reporter cell 
line inducibly expressing GFP-CDC25A has a functional checkpoint responding to IR-
induced DNA damage with CDC25A degradation. 
 
 
Figure 2.6: The reporter cell line inducibly expressing GFP-CDC25A responds to IR by 
accelerated GFP-CDC25A degradation. (A) Microscopy images of IR-induced GFP-CDC25A 
degradation. GFP-CDC25A expression of the stably transfected U2OS cells was induced by 
doxycycline treatment for 24 h. Then, the cells were mock-irradiated or irradiated with 10 Gy 
and treated with 50 μg/mL CHX to inhibit protein re-synthesis. After 0, 30, or 60 min, the cells 
were fixed with paraformaldehyde and stained with DAPI. GFP-CDC25A expression was 
examined by fluorescence microscopy. Scale bar: 100 µm. (B) Quantification of A. Shown are 
means of three independent experiments and error bars represent s.d. *** p < 0.001. GFP 
intensity was quantified by ImageJ. (C) Immunoblot of IR-induced GFP-CDC25A degradation. 
GFP-CDC25A expression was induced by doxycycline for 6 h. The cells were mock-irradiated 
or irradiated with 10 Gy and treated with 50 μg/mL CHX. After 0, 30, or 60 min, the cells were 
lysed and cell lysates were subjected to SDS-PAGE and Western blotting. GFP-CDC25A was 
detected by an anti-CDC25A antibody. α-tubulin (Tub) served as loading control. (D) 
Quantification of C. Signal density on X-ray films was quantified using BIO1D. GFP-CDC25A 
levels without CHX were set to 100% for each condition. 
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2.2.3 GFP-CDC25A degradation is dependent on p97, Npl4, and UBXD7 
Next, it was explored if the dependency on p97Ufd1-Npl4 for the degradation of 
endogenous CDC25A is also seen with GFP-CDC25A degradation. For this purpose, 
irradiation was combined with siRNA-mediated depletions of the p97 cofactors Ufd1 or 
Npl4 in a CHX chase. First, the U2OS Flp-In cells were mock-transfected with a non-
targeting siRNA (siCtrl) or transfected with siRNAs targeting Ufd1, Npl4, or the F-box 
protein βTrCP for 48 h. SCFβTrCP was shown to be the E3 ubiquitin ligase responsible 
for CDC25A ubiquitylation and therefore served as a positive control (Busino et al, 
2003; Kanemori et al, 2005). During the last 6 h of depletion, GFP-CDC25A expression 
was induced by addition of doxycycline. Then, the cells were mock-irradiated or 
irradiated with 10 Gy and CHX was added. At different time points (0, 30, or 60 min) 
the cells were lysed and cell lysates were examined by Western blotting (Fig. 2.7). 
 
 
Figure 2.7: Knockdown of Npl4 leads to delayed GFP-CDC25A degradation after IR-
induced DNA damage. (A) CHX chase of IR-induced GFP-CDC25A degradation in depleted 
cells. U2OS cells inducibly expressing GFP-CDC25A were mock-depleted or depleted of Ufd1, 
Npl4, or βTrCP for 48 h. GFP-CDC25A expression was induced during the last 6 h of depletion. 
Subsequently, the cells were mock-treated or treated with 10 Gy of IR and 50 μg/mL CHX to 
inhibit protein re-synthesis. After 0, 30, or 60 min, the cells were lysed and cell lysates were 
subjected to SDS-PAGE and Western blotting. GFP-CDC25A was detected by an anti-CDC25A 
antibody. α-tubulin (Tub) served as loading control. (B) Quantification of A. Shown are means of 
three independent experiments and error bars represent s.d. * p < 0.05, *** p < 0.001. Signal 
density on X-ray films was quantified using BIO1D. GFP-CDC25A levels without IR were set to 
100% for each depletion. 
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In control-depleted cells, GFP-CDC25A was degraded rapidly upon IR. Since βTrCP is 
the ligase that ubiquitylates CDC25A, thereby labeling it for degradation, βTrCP 
knockdown led to a marked increase in GFP-CDC25A levels and a significantly 
delayed degradation (Fig. 2.7A and B). GFP-CDC25A degradation was also 
significantly delayed upon Npl4 depletion, though to a lesser extent than upon βTrCP 
depletion. Interestingly, GFP-CDC25A levels in Npl4-depleted cells were increased in 
non-irradiated cells as well, indicating that Npl4, like βTrCP, mediates GFP-CDC25A 
destruction even in the absence of DNA damage. However, in contrast to knockdown 
of βTrCP and to our results for endogenous CDC25A, 60 min after irradiation GFP-
CDC25A levels were hardly detectable in Npl4-depleted cells. Furthermore, in contrast 
to Npl4 depletion and unlike in experiments following endogenous CDC25A 
degradation, knockdown of Ufd1 did not affect GFP-CDC25A turnover compared to 
control-depleted cells. 
Since the observation for Ufd1-depleted cells was contradictory to our results for 
endogenous CDC25A degradation, several siRNAs targeting Ufd1 were tested for their 
ability to stabilize GFP-CDC25A levels after DNA damage. To this end, the experiment 
was repeated with five different oligonucleotides able to downregulate Ufd1, named S1 
to S5 (Fig. 2.8). In this experiment, samples were taken 0 and 60 min after IR. 
Intriguingly, knockdown of Ufd1 with any tested oligonucleotide led to a decrease in 
GFP-CDC25A levels compared to control-depleted cells, albeit to a different extent. 
However, all tested oligonucleotides depleted cells of Ufd1 to the same level. 
Moreover, none of the siRNAs targeting Ufd1 stabilized GFP-CDC25A after IR. In the 
previous experiment, the S2 oligo was used (Fig. 2.7). 
 
 
Figure 2.8: Knockdown of Ufd1 does not stabilize GFP-CDC25A after IR-induced DNA 
damage. U2OS cells inducibly expressing GFP-CDC25A were mock-depleted or depleted of 
Ufd1 or βTrCP for 48 h. For Ufd1 depletion, five different siRNAs named S1 to S5 were tested. 
GFP-CDC25A expression was induced during the last 6 h of depletion. Subsequently, the cells 
were mock-treated or treated with 10 Gy of IR and 50 μg/mL CHX to inhibit protein re-synthesis. 
After 0 or 60 min, the cells were lysed and cell lysates were subjected to SDS-PAGE and 
Western blotting. GFP-CDC25A was detected by an anti-CDC25A antibody. α-tubulin (Tub) 
served as loading control. 
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As the reporter cell line inducibly expressing GFP-CDC25A responded to Npl4 and 
βTrCP knockdown similar to our observations for endogenous CDC25A, we 
investigated if UBXD7 participates in GFP-CDC25A turnover. For this purpose, the 
CHX chase was performed with siRNAs targeting UBXD7 or the negative control 
UBXD8, a p97 cofactor involved in ERAD. Interestingly, depletion of UBXD7 caused 
GFP-CDC25A stabilization and delayed degradation to the same extent as Npl4 
depletion, whereas knockdown of UBXD8 did not affect GFP-CDC25A turnover (Fig. 
2.9). 
 
 
Figure 2.9: Knockdown of UBXD7 leads to delayed GFP-CDC25A degradation after IR-
induced DNA damage. (A) CHX chase of IR-induced GFP-CDC25A degradation in depleted 
cells. U2OS cells inducibly expressing GFP-CDC25A were mock-depleted or depleted of 
UBXD7, UBXD8, or βTrCP for 48 h. GFP-CDC25A expression was induced during the last 6 h 
of depletion. Subsequently, the cells were mock-treated or treated with 10 Gy IR and 50 μg/mL 
CHX to inhibit protein re-synthesis. After 0, 30, or 60 min, the cells were lysed and cell lysates 
were subjected to SDS-PAGE and Western blotting. GFP-CDC25A was detected by an anti-
CDC25A antibody. GAPDH served as loading control. (B) Quantification of A. Shown are 
means of three independent experiments and error bars represent s.d. * p < 0.05, *** p < 0.001. 
Signal density on X-ray films was quantified using BIO1D. GFP-CDC25A levels without IR were 
set to 100% for each depletion. 
 
Taken together, these results show that Npl4 and UBXD7 participate in GFP-CDC25A 
degradation. However, Ufd1 knockdown caused a marked decrease in GFP-CDC25A 
levels. In contrast, we showed that depletion of Ufd1 stabilized endogenous CDC25A. 
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2.3 Unrepaired DNA damage from interphase leads to segregation 
errors in mitosis in cells depleted of p97Ufd1-Npl4 
In 2011, our laboratory showed that knockdown of the p97 cofactor Ufd1-Npl4 by 
siRNA caused defects in chromosome segregation during mitosis due to upregulated 
Aurora B kinase activity (Dobrynin et al, 2011). This demonstrated that p97Ufd1-Npl4 
antagonizes Aurora B which functions in the bipolar attachment of the mitotic spindle to 
the centromeres of the chromosomes. Moreover, we found that depletion of p97Ufd1-Npl4 
impaired the G2/M checkpoint by stabilizing CDC25A (Riemer et al, 2014). Since p97 is 
also implicated in diverse interphase functions, we were interested if the severe 
segregation defects observed in Ufd1-Npl4-depleted cells only originate from impaired 
mitotic functions of p97Ufd1-Npl4 or if they additionally arise from replication-associated 
damage carried over into mitosis due to the G2/M checkpoint override. 
To explore to what extent pre-mitotic functions of p97Ufd1-Npl4 affect chromosome 
stability in human cells, mitotic segregation errors of HeLa cells depleted of p97, Ufd1, 
Npl4, or DVC1 were analyzed by light microscopy. Errors of mitotic or pre-mitotic origin 
were distinguished by staining of the centromere with CREST (Burrell et al, 2013). 
Lagging chromosomes in anaphase comprising a centromere were considered to result 
from defects in mitotic functions, whereas chromosome fragments without centromere 
and anaphase bridges were considered to be of pre-mitotic origin (Fig. 2.10A). 
HeLa cells were mock-transfected with siluc or transfected with siRNAs targeting p97, 
Ufd1, Npl4, DVC1, or Chk1 for 48 h. Knockdown of Chk1 served as a positive control. 
All depletions led to an increase of acentric chromosomal fragments or chromosome 
bridges over control cells, when the cells were additionally challenged with 0.2 µM 
aphidicolin (APH), an inhibitor of DNA polymerases α and δ, for 24 h (Fig. 2.10B and 
C). This increase in mitotic defects of pre-mitotic origin suggests unrepaired or 
incompletely replicated DNA. Notably, cells depleted of Chk1 were apoptotic upon 
additional APH treatment indicating high levels of DNA damage. Therefore, the number 
of mitotic cells was too low to determine the percentage of cells with errors of mitotic or 
pre-mitotic origin. Taken together, there is evidence that p97Ufd1-Npl4 suppresses 
chromosomal instability that stems from defects in interphase. 
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Figure 2.10: Unrepaired DNA damage after replication stress results in severe 
chromosome segregation defects in mitotic cells depleted of p97, Ufd1, Npl4, or DVC1. 
(A) Schematic illustration of mitotic and pre-mitotic defects in anaphase. Blue depicts chromatin, 
red dots depict centromeres. (B) Confocal micrographs of mitotic HeLa cells in anaphase 
depleted with the indicated siRNAs for 48 h and treated with DMSO or aphidicolin (APH) as 
depicted. Cells were fixed 24 h after DMSO or APH treatment and stained with DAPI and 
CREST antibodies to visualize chromatin and centromeres, respectively. RNAi against 
luciferase served as negative control, RNAi against Chk1 as positive control. n.d.: not 
determined due to low number of mitotic cells. Merge: DAPI – cyan, CREST – red. Scale bar: 
10 μm. (C) Quantification of B according to classification in A. Shown are means of three 
independent experiments with at least 25 cells per condition and error bars represent s.d. 
* p < 0.05. 
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2.4 Knockdown of p97 sensitizes HeLa cells to replication stress-
inducing drugs 
Given that replication stress contributes to chromosomal instability in cells depleted of 
p97 and its cofactors Ufd1-Npl4 and DVC1, respectively, we asked if these proteins are 
important for survival of human tumor cells after replication stress. In addition, we 
included UBXD7 in this study due to the finding that it is crucial for NER. In this setting, 
we applied replication stress in form of increasing concentrations of cisplatin or 
doxorubicin. Cisplatin is a DNA crosslinker binding to two adjacent DNA bases either 
within the same DNA strand (intrastrand-crosslinks) or from opposing DNA strands 
(interstrand-crosslinks). In contrast, doxorubicin intercalates into DNA, thereby 
inhibiting topoisomerase II, which resolves DNA daughter molecules after replication. 
To examine if p97 and its cofactors are crucial for survival of human tumor cells after 
replication stress, a cell viability assay was performed. For this purpose, the MTS 
assay was chosen. MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium) is a tetrazolium salt, which is reduced to a formazan 
product by NAD(P)H in the presence of phenanzine methosulfate (PMS) that acts as 
an intermediate electron acceptor. Thus, the amount of produced formazan 
corresponds proportionally to glycolysis rate. This reaction can be followed 
spectrophotometrically at 490 nm. 
First, HeLa cells were mock-transfected with siluc or transfected with siRNAs targeting 
p97, Ufd1, Npl4, UBXD7 or DVC1 for 48 h. Then, cells were treated with increasing 
concentrations of the DNA crosslinker cisplatin (5-25 µM) or the topoisomerase II 
inhibitor doxorubicin (1-3 µM) for further 24 h to induce replication stress. Finally, MTS 
was added for 1 h and cell viability was determined spectrophotometrically. 
p97-depleted cells were significantly more sensitive to increasing concentrations of 
cisplatin and doxorubicin than mock-depleted cells (Fig. 2.11A and B), while cells 
depleted of UBXD7 or DVC1 were not (Fig. 2.11G and H). Knockdown of Ufd1 or Npl4 
only showed a slightly elevated sensitivity to cisplatin at high concentrations (Fig. 
2.11C and E). In contrast, sensitivity to doxorubicin was significantly increased in Ufd1- 
or Npl4-depleted cells (Fig. 2.11D and F), albeit to a lesser extent than upon p97 
depletion. This indicates that p97Ufd1-Npl4 is involved in the response to replication stress 
and plays an important role in cell survival after DNA damage in S phase. 
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Figure 2.11: Cell survival of HeLa cells after knockdown of p97 or its cofactors and 
additional replication stress. HeLa cells were depleted of p97 (A, B), Ufd1 (C, D), Npl4 (E, F), 
UBXD7 (G, H) or DVC1 (I, J) for 48 h and challenged with increasing concentrations of the 
replication stress-inducers cisplatin (A, C, E, G, I) or doxorubicin (B, D, F, H, J) for further 24 h. 
Cell viability was determined by an MTS assay. RNAi against luciferase served as control. Data 
were collected in technical triplicates. Shown are means of three independent experiments and 
error bars represent s.d. * p < 0.05, ** p < 0.01, *** p < 0.001. Cell viability without replication 
stress was set to 100% for each depletion (for starting values see Fig. 2.12). 
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Notably, without additional challenge by cisplatin or doxorubicin, knockdown of p97 or 
Npl4 caused a significant reduction in cell proliferation over control cells in contrast to 
knockdown of the other analyzed proteins (Fig. 2.12). 
 
 
Figure 2.12: Cell survival of HeLa cells after knockdown of p97 or its cofactors. Cell 
viability was measured with an MTS assay after siRNA-mediated depletion of p97, Ufd1, Npl4, 
UBXD7 or DVC1 for 72 h. RNAi against luciferase served as control. Data were collected in 
technical triplicates. Shown are means of three independent experiments and error bars 
represent s.d. * p < 0.05, *** p < 0.001. 
 
2.5 UBXD7 is not required for the degradation of all CRL substrates 
Recently, the p97 adaptor UBXD7 was shown to be involved in the cellular response to 
DNA damage (Verma et al, 2011; Puumalainen et al, 2014; He et al, 2016). A unique 
feature of UBXD7 is its UIM domain which allows direct binding to neddylated CRLs 
(Alexandru et al, 2008; Bandau et al, 2012; den Besten et al, 2012). To date, only 
nuclear targets were confirmed for UBXD7, including CDC25A (own data), HIF1α, 
Rpb1, DDB2, and CSB (Alexandru et al, 2008; Verma et al, 2011; Puumalainen et al, 
2014; He et al, 2016). However, the direct link of UBXD7 to p97 and to CRLs posed the 
question if UBXD7 is generally involved in CRL- and p97-dependent degradation both 
in the nucleus and in the cytoplasm. To address this issue, we examined degradation 
of the cytoplasmic inhibitor of NF-κB, IκBα. Cytokine-induced proteolysis of IκBα was 
shown to depend on the cullin RING ligase SCFβTrCP and p97Ufd1-Npl4 (Li et al, 2014). To 
determine if UBXD7 also participates in IκBα turnover, the degradation was monitored 
by immunoblot analysis. 
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Figure 2.13: In contrast to p97
Ufd1-Npl4
, UBXD7 is not required for TNFα-induced IκBα 
degradation. HeLa cells were mock-transfected or depleted of p97, Ufd1, Npl4, UBXD7, the 
ERAD factor UBXD8, or the proteasomal subunit PSMB5 for 48 h. IκBα ubiquitylation and 
degradation was induced by treatment with the cytokine TNFα. After 0, 3, 6, or 12 min, the cells 
were lysed and cell lysates were analyzed by Western blotting to detect unmodified and 
ubiquitylated IκBα. α-tubulin (Tub) served as loading control. 
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HeLa cells were either mock-transfected or transfected with siRNA targeting p97, its 
cofactors Ufd1, Npl4, UBXD7, or UBXD8, or PSMB5, which is a subunit of the 26S 
proteasome. Turnover of IκBα was induced by addition of TNFα for 0, 3, 6, or 12 min. 
Then, the cells were lysed and cell lysates were subjected to SDS-PAGE and Western 
blotting. To prevent deubiquitination, the DUB inhibitor PR619 and N-ethylmaleimide 
(NEM) were added to the lysis buffer.  
In control cells, IκBα was rapidly degraded within 12 min after TNFα addition (Fig. 
2.13). Consistent with other findings, knockdown of the proteasomal subunit PSMB5 
had no impact on the abundance of IκBα, indicating that IκBα is stable in HeLa cells 
under unstimulated conditions. Moreover, depletion of PSMB5, p97, Ufd1, or Npl4 
clearly delayed IκBα degradation, confirming that turnover of IκBα is mediated by the 
proteasome with the help of p97Ufd1-Npl4. In addition to unmodified IκBα, the anti-IκBα 
antibody recognized proteins with high molecular weight which are supposed to be 
ubiquitylated forms of IκBα. Ubiquitylated IκBα (IκBαUb) was strongly increased upon 
knockdown of p97, Ufd1, Npl4 or PSMB5 and the accumulation of IκBαUb was shifted to 
later time points after TNFα induction compared to control cells. This further confirms 
that p97Ufd1-Npl4 and the 26S proteasome are essential for IκBα degradation 
downstream of ubiquitylation. In contrast, depletion of UBXD7 or the p97 cofactor 
UBXD8 that is involved in ERAD had no effect on IκBα turnover. Hence, this indicates 
that UBXD7 is not essential for all CRL substrates. 
 
2.6 Binding to p97 and CRLs is essential for UBXD7 function 
To shed light on the relevance of the various UBXD7 domains for its function, a 
structure-function analysis of UBXD7-mediated degradation was performed. For this 
purpose, the well-established UBXD7 substrate DDB2 was used (Puumalainen et al, 
2014). DDB2 is rapidly recruited to DNA lesion sites after UV irradiation and is then 
ubiquitylated by CUL4A and degraded by the proteasome. It was shown that DDB2 
degradation after UV irradiation is dependent on p97Ufd1-Npl4 and UBXD7 in HEK293 
cells. To confirm this finding for U2OS cells, which we used for the structure-function 
analysis of UBXD7, an immunoblot analysis of UV light-treated U2OS cells was 
performed. 
Therefore, U2OS cells were mock-transfected or transfected with siRNAs targeting 
p97, Npl4, Ufd1, UBXD7, or UBXD1, a p97 cofactor implicated in endolysosomal 
sorting. The depleted cells were either mock-treated or exposed to UV light (10 J/m2), 
before they were lysed 60 min later and subjected to SDS-PAGE and Western blotting. 
In control cells, DDB2 was degraded 60 min after UV radiation (Fig. 2.14). Consistent 
with the finding in HEK293 cells, knockdown of p97, Npl4, Ufd1, or UBXD7 reduced 
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UV light-triggered breakdown of DDB2 in U2OS cells, indicating that p97Ufd1-Npl4 and 
UBXD7 are required for DDB2 degradation. As expected, depletion of UBXD1 did not 
affect DDB2 turnover. 
 
 
Figure 2.14: UV light-triggered degradation of DDB2 is inhibited in cells treated with 
siRNAs targeting p97, Npl4, Ufd1, or UBXD7. U2OS cells were treated with siRNAs against 
p97, Npl4, Ufd1, UBXD7, UBXD1, or non-targeting control (siCtrl) for 48 h. DDB2 degradation 
was induced by UV irradiation (10 J/m
2
). After 60 min, the cells were lysed and cell lysates were 
analyzed by Western blotting to detect DDB2 levels. α-tubulin (Tub) served as loading control. 
 
Next, it was investigated if the inhibition of UV light-induced DDB2 breakdown can be 
rescued by additional overexpression of RNAi-resistant wild-type UBXD7 (UBXD7 wt). 
Therefore, U2OS cells were treated with siRNAs against UBXD7 or non-targeting 
control. After 24 h, the cells were additionally transfected with UBXD7 wt-strep-HA or 
empty vector. Another 24 h later, the cells were either mock-treated or exposed to UV 
radiation (10 J/m2), before they were lysed 15 or 60 min later and subjected to SDS-
PAGE and Western blotting. 
In control-depleted cells, DDB2 was degraded within 60 min after UV light exposure 
irrespective of additional transfection with UBXD7 wt-strep-HA (Fig. 2.15). 
Overexpression of UBXD7 wt-strep-HA was confirmed by staining with an anti-HA 
antibody. Consistent with the previous experiment, depletion of UBXD7 led to 
persistent DDB2 after UV irradiation. However, additional overexpression of UBXD7 wt-
strep-HA was able to rescue inhibited UV light-triggered DDB2 degradation in cells 
depleted of endogenous UBXD7. Residual staining of UBXD7 at about 70 kDa in cells 
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depleted of endogenous UBXD7 and transfected with RNAi-resistant UBXD7 wt-strep-
HA is likely to result from overexpressed UBXD7 wt-strep-HA lacking the C-terminal 
strep-HA tag instead of from incomplete depletion of endogenous UBXD7. 
 
 
Figure 2.15: Overexpression of UBXD7 wt rescues inhibited UV light-induced DDB2 
degradation in cells depleted of endogenous UBXD7. U2OS cells were treated with siRNAs 
against UBXD7 or non-targeting control (siCtrl) for 48 h. After 24 h of incubation, the cells were 
additionally transfected with UBXD7 wt-strep-HA or empty vector. DDB2 degradation was 
induced by UV irradiation (10 J/m
2
). After 0, 15, and 60 min, the cells were lysed and cell 
lysates were analyzed by Western blotting to detect DDB2 levels. Overexpression of UBXD7 wt-
strep-HA was confirmed by HA staining, depletion of endogenous UBXD7 by UBXD7 staining. 
α-tubulin (Tub) served as loading control. 
 
Finally, the rescue experiment was applied to perform a structure-function analysis of 
UBXD7. UBXD7 contains an N-terminal UBA domain, followed by a UAS domain, a 
UIM and a C-terminal UBX domain (Fig. 2.16A). The UBA domain is able to bind 
ubiquitin, whereas the UAS domain is of unknown function. UBXD7 was shown to bind 
neddylated CRLs via its UIM which associates directly with NEDD8, but can also bind 
ubiquitin (Fisher et al, 2003; Bandau et al, 2012; den Besten et al, 2012). Interaction 
with p97 is mediated by the UBX domain. To investigate the requirement of the 
different domains for UBXD7 function in DDB2 degradation, the ability of UBXD7 
mutants to rescue impaired DDB2 turnover in UBXD7-depleted cells was compared. 
Therefore, different mutants of UBXD7 were generated by Lena Weimann, including 
deletion mutants lacking the UBA, UAS or UIM domain as well as a UBXD7 variant with 
a point-mutation in the UBX domain which was shown to be deficient in p97-binding 
(P459G; Bandau et al, 2012). 
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Figure 2.16: Structure-function analysis of UBXD7 in UV light-triggered DDB2 
degradation. (A) Schematic representation of UBXD7 wt and UBXD7 mutants highlighting their 
various domains. UBA, ubiquitin-associated domain; UAS, ubiquitin-associating domain; UIM, 
ubiquitin-interacting motif; UBX, ubiquitin regulatory X domain; aa, amino acids. (B) U2OS cells 
were treated with siRNA targeting UBXD7 or non-targeting control (siCtrl) for 48 h. After 24 h of 
incubation, the cells were additionally transfected with empty vector, UBXD7 wt, or the indicated 
mutants. DDB2 degradation was induced by UV irradiation (10 J/m
2
). After 60 min, the cells 
were lysed and cell lysates were analyzed by Western blotting to detect DDB2 levels. 
Overexpression of UBXD7 wt and the mutants was confirmed by UBXD7 staining. α-tubulin 
(Tub) served as loading control. 
 
To evaluate the role of UBXD7’s four domains for its function in DDB2 degradation, the 
generated constructs were expressed in U2OS cells depleted of endogenous UBXD7 
and their ability to rescue DDB2 degradation was determined (Fig. 2.16B). Consistent 
with the previous experiments, DDB2 was destroyed 60 min after UV light exposure in 
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control-depleted cells. Knockdown of UBXD7 stabilized DDB2 after UV irradiation, 
whereas additional overexpression of RNAi-resistant UBXD7 wt rescues DDB2 
turnover. Expression of UBXD7_ΔUBA was able to almost completely rescue DDB2 
degradation in UBXD7-depleted cells. Furthermore, DDB2 destruction in cells lacking 
endogenous UBXD7 could be partially rescued by overexpression of UBXD7_ΔUAS. In 
contrast, UBXD7_ΔUIM and UBXD7_P459G did not affect DDB2 stabilization in 
UBXD7-depleted cells. 
Taken together, the results of this experiment indicate that p97-binding and association 
with neddylated CRLs is essential for UBXD7 function in DDB2 degradation. In 
contrast, the ability of UBXD7 to bind ubiquitin does not seem to be required for proper 
UBXD7 function. The role of the UAS domain needs to be further investigated, since its 
function is still unknown. 
 
2.7 Different p97 inhibitors elicit diverse effects 
In addition to siRNA-mediated downregulation, chemical inhibition of p97 with small-
molecule inhibitors provides an advantageous tool to explore p97 function in cells. 
Recently, our lab obtained the unpublished inhibitors I1, I5, and I8 to analyze their 
potential as p97 inhibitors for laboratory use. 
 
2.7.1 Differential effects of p97 inhibitors on cell viability 
In order to characterize these different first-generation p97 inhibitors, first the 
cytotoxicity of these inhibitors was investigated. To test this, HeLa cells were treated 
with increasing concentrations (1-35 µM) of five different p97 inhibitors (DBeQ, NMS-
873, as well as the unpublished compounds I1, I5, and I8). After 5, 16, or 24 h of 
treatment, cell viability was measured with the MTS assay (Fig. 2.17). 
Cell death was observed with increasing concentrations and incubation times. Data 
analysis revealed a cytotoxic effect of the p97 inhibitors after 24 h treatment in the 
following order of potency: NMS-873 > I8 > I5 > I1 ≥ DBeQ > NMS-859 (Fig. 2.17C). 
However, this order was not observed for the shorter time points. After 5 h or 16 h of 
p97 inhibition, NMS-873 just had a minor effect on cell survival, even at high 
concentrations (Fig. 2.17A and B). Still, at low concentrations up to 10 µM, NMS-873 
was the most potent p97 inhibitor tested. At higher concentrations, I8 emerged as the 
most potent p97 inhibitor. Since I8 was more potent than the other unpublished p97 
inhibitors, we decided to continue experiments on p97 inhibition with DBeQ, I8, and 
NMS-873. 
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Figure 2.17: Cell survival of HeLa cells after p97 inhibiton. HeLa cells were treated with 
increasing concentrations of different p97 inhibitors for 5 h (A), 16 h (B), or 24 h (C). Cell 
viability was determined by an MTS assay. Data were collected in technical triplicates. Shown 
are means of three independent experiments and error bars represent s.d. 
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2.7.2 p97 inhibition with NMS-873 showed synthetic lethality with doxorubicin 
In the next step, it was examined if pharmacological inhibition of p97 sensitizes human 
cancer cells to replication stress-inducing drugs, as observed in the case of p97 RNAi 
knockdown. For this purpose, HeLa cells were treated with increasing concentrations of 
cisplatin (5-25 µM) or doxorubicin (1-5 µM) together with either solvent (DMSO) or 
3 µM DBeQ, 3 µM I8, or 3 µM NMS-873 for 24 h, before cell viability was determined 
with an MTS assay. The concentrations of p97 inhibitors were chosen based on 
preserving cell viability after 24 h. 
 
 
Figure 2.18: Cell survival of HeLa cells after p97 inhibition and additional replication 
stress. HeLa cells were simultaneously treated with 3 µM DBeQ (A, B), 3 µM I8 (C, D), or 3 µM 
NMS-873 (E, F) and increasing concentrations of the replication stress-inducers cisplatin (A, C, 
E) or doxorubicin (B, D, F) for 24 h. Cell viability was determined by an MTS assay. DMSO 
served as control. Data were collected in technical triplicates. Shown are means of three 
independent experiments and error bars represent s.d. * p < 0.05. 
 
Inhibition of p97 showed no sensitization to cisplatin under the given conditions (Fig. 
2.19A, C, and E). For doxorubicin treatment, only p97 inhibition with NMS-873 but not 
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with DBeQ or I8 showed significant synthetic lethality (Fig. 2.19B, D, and F). In 
summary, only p97 inhibition with NMS-873 potently sensitized human cancer cells to 
replication stress, albeit less efficiently than p97 depletion. 
 
2.7.3 NMS-873 delayed GFP-CDC25A degradation after IR 
To further analyze if the tested p97 inhibitors are useful tools for investigating p97 
functions, their effect on the degradation of the p97 target CDC25A was explored. 
Therefore, the GFP-CDC25A reporter cell line was induced with doxycycline for 6 h. 
The cells were either treated with solvent (DMSO), or 10 µM DBeQ, 10 µM I8, 5 µM 
NMS-873, or 10 µM MG132 for 30 min. Treatment with the proteasome inhibitor 
MG132 served as a positive control. Then, the cells were irradiated with 10 Gy and 
CHX was added to block protein re-synthesis. Afterwards, the cells were lysed and cell 
lysates were analyzed by Western blotting. 
In DMSO-treated cells, GFP-CDC25A was degraded within 60 min after IR with 10 Gy 
(Fig. 2.20). Moreover, proteasome inhibition with MG132 caused a significant delay in 
GFP-CDC25A degradation. Notably, inhibition of p97 with DBeQ or NMS-873 led to 
increased levels of GFP-CDC25A in general. However, while NMS-873 delayed 
degradation after IR compared to solvent-treated cells to a similar extent like MG132, 
DBeQ as well as I8 did not affect GFP-CDC25A degradation. 
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Figure 2.19: p97 inhibition with NMS-873 delayed GFP-CDC25A degradation after IR-
induced DNA damage. (A) CHX chase of IR-induced CDC25A degradation after p97 inhibition. 
U2OS cells inducibly expressing GFP-CDC25A were mock-treated with solvent (DMSO) or 
inhibited of p97 with DBeQ, I8, or NMS-873 for 24 h. Treatment with the proteasome inhibitor 
MG-132 served as positive control. GFP-CDC25A expression was induced during the last 6 h of 
p97 inhibition. Subsequently, the cells were mock-treated or treated with 10 Gy IR and 
50 μg/mL CHX to inhibit protein re-synthesis. After 0, 30, or 60 min, the cells were lysed and cell 
lysates were subjected to SDS-PAGE and Western blotting. GFP-CDC25A was detected by an 
anti-CDC25A antibody. α-tubulin (Tub) served as loading control. (B) Quantification of A. Shown 
are means of three independent experiments and error bars represent s.d. * p < 0.05, 
*** p < 0.001. Signal density on X-ray films was quantified using BIO1D. GFP-CDC25A levels 
without IR were set to 100% for each treatment. 
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3 Discussion 
At the beginning of this thesis, little was known about the role of p97 in the cell cycle 
and the DNA damage response. While it was already clear that p97 is important for 
mitosis, there was increasing evidence from different organisms for p97 being involved 
in interphase functions. To investigate a possible implication of p97 in the response to 
replication stress and DNA damage in human cells and to evaluate the relevance of 
these functions, we focused on three major aspects. The first goal of this work was to 
clarify if p97 helps to maintain a DNA damage checkpoint. Next, we evaluated the 
significance of p97 and its cofactors for survival of human cancer cells after replication 
stress. This included the examination of possible synergistic effects of novel p97 
inhibitors with genotoxic chemotherapeutic agents and their influence on the DNA 
damage response. However, several studies on the role of p97 in DNA replication and 
replication-associated repair pathways were published during the period of this work. 
For this reason, after publishing our study on the relevance of p97Ufd1-Npl4 for the 
robustness of the G2/M checkpoint (Riemer et al, 2014), we refocused our studies on 
the p97 adaptor UBXD7 that has been recently linked to DNA repair (Verma et al, 
2011; Puumalainen et al, 2014; He et al, 2016). This included an analysis of the role of 
UBXD7 for diverse p97 substrate proteins including CDC25A and a detailed structure-
function analysis of UBXD7 to explore its functional relationship to p97. 
 
3.1 p97 in cell cycle checkpoints 
In the first part of this thesis, we wanted to clarify a possible involvement of p97 in the 
maintenance of a DNA damage checkpoint. Data from colleagues and from this study 
show that, while the p97Ufd1-Npl4 complex may only play a minor role in the G1/S and 
intra S checkpoint, p97Ufd1-Npl4 is required for activation of the G2/M checkpoint 
(published in Riemer et al, 2014). This work contributed to the finding that, in the G2/M 
checkpoint, p97 facilitates CDC25A degradation and thereby ensures robustness of the 
checkpoint. 
After the confirmation of CDC25A being the p97 target in the G2/M checkpoint, we 
aimed to further analyze the role of p97 and its cofactors in CDC25A degradation by 
fluorescence microscopy. For this purpose, a U2OS reporter cell line expressing GFP-
CDC25A under control of a doxycycline-inducible promoter was generated and 
characterized. The cell line was sensitive to IR, since GFP-CDC25A degradation was 
accelerated after IR compared to non-irradiated cells. Moreover, depletion of βTrCP 
and Npl4 led to increased levels of GFP-CDC25A and a delay in its degradation, 
consistent with our findings for the degradation of endogenous CDC25A in HeLa cells. 
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However, siRNA-mediated knockdown of Ufd1 with five different oligonucleotides 
caused a pronounced decrease in GFP-CDC25A levels in contrast to our findings for 
endogenous CDC25A, which was stabilized upon Ufd1 depletion to even higher levels 
than upon Npl4 depletion (Riemer et al, 2014). Thus, we assume that the observed 
reduction of GFP-CDC25A levels in Ufd1-depleted cells of the U2OS-FRT-TO reporter 
cell line is probably an off-target effect. It remains unclear why the reporter cell line 
responds differently to Ufd1 depletion than normal HeLa cells. Yet, the cell line does 
not only show delayed degradation of GFP-CDC25A after the depletion of βTrCP or 
Npl4, but also after the depletion of UBXD7 which was shown for the first time in this 
work and only later confirmed for endogenous CDC25A. Furthermore, we observed 
that p97 inhibition with NMS-873 stabilized GFP-CDC25A to a similar extent as 
proteasome inhibition with MG132 and significantly delayed IR-induced GFP-CDC25A 
degradation. In contrast, RNAi-mediated knockdown of p97 did not compromise the 
degradation of endogenous CDC25A as described in the PhD thesis by Dr. Grzegorz 
Dobrynin. This effect was explained by the impairment of a wide variety of p97-
dependent pathways upon p97 knockdown and a subsequent checkpoint adaptation. 
Interestingly, the depletion of p97 resulted in reduced levels of WEE1 which is the 
counteracting kinase of the CDC25A phosphatase in the G2/M checkpoint. Why p97 
inhibition leads to a different phenotype than p97 depletion remains elusive. Most likely, 
these observations are due to remaining p97 ATPase activity upon NMS-873 
treatment, in contrast to depletion of p97 where p97 ATPase activity is almost absent. 
Nevertheless, the discrepancy in our observations for endogenous CDC25A in HeLa 
cells and overexpressed GFP-CDC25A in U2OS-FRT-TO cells upon Ufd1 depletion led 
us to the decision that the U2OS-FRT-TO reporter cell line is not suitable for further 
studies. 
 
The evidence for p97Ufd1-Npl4 being required to activate the G2/M checkpoint by 
facilitating CDC25A degradation led us to ask, whether p97 is also involved in CDC25A 
degradation in the G1/S and intra S checkpoint. Our results showed that depletion of 
Ufd1 or Npl4 did not affect the G1/S checkpoint, but p97Ufd1-Npl4 may play a minor role in 
the intra S checkpoint. In contrast, DVC1 is important for the intra S checkpoint. It 
remains unclear, if DVC1 has a direct role in the checkpoint itself or if this is rather an 
indirect effect due to the role of DVC1 in DNA replication. Cells depleted of DVC1 
continue replication after DNA damage, probably because DVC1 is crucial for TLS, a 
strategy of the cell to bypass replication-blocking lesions (Centore et al, 2012; Davis et 
al, 2012; Ghosal et al, 2012; Juhasz et al, 2012; Machida et al, 2012; Mosbech et al, 
2012; Kim et al, 2013). An intact intra S checkpoint requires the activation of TLS to 
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allow DNA repair and this process is accompanied by retarded DNA synthesis. 
Replication forks encountering DNA lesions stall because replicative polymerases 
cannot accommodate bulky lesions in their active sites. Lesion bypass is achieved by a 
switch to translesion polymerases that are able to accommodate damaged bases. 
It is under debate, if DVC1 removes the replicative Polδ at UV lesions to allow 
recruitment of the TLS polymerase Polη (Ghosal et al, 2012; Juhasz et al, 2012), or if 
DVC1 recruits p97 to stalled replication forks to extract Polη and allow the switch back 
to replicative polymerases after bypassing the UV lesion (Davis et al, 2012; Mosbech et 
al, 2012). Our data rather support the model that DVC1 is involved in the switch from 
normal replication to TLS, because cells with impaired DVC1 did not exhibit a slower 
DNA synthesis, which would be expected for an intact TLS activation. However, we 
applied DNA damage in the form of IR instead of UV damage. UV light mainly induces 
the formation of CPDs and 6-4PPs which can be bypassed by TLS, whereas IR rather 
provokes DSBs that are repaired by HR or NHEJ. If and how DVC1 is involved in the 
repair of DSBs occurring during S phase remains to be clarified. 
 
3.2 p97 in replication 
In addition to the checkpoints, we examined the function of p97 and its cofactors in 
DNA replication and the replication stress response. Intriguingly, while we observed 
only a minor role of p97 in the intra S checkpoint, BrdU as well as 3H-thymidine 
incorporation into newly synthesized DNA revealed a significant reduction in DNA 
synthesis upon p97 depletion in non-irradiated cells. The same holds true for depletion 
of DVC1. This demonstrates that p97 and DVC1 are essential for efficient DNA 
replication. 
Consistent with this, inactivation of the CDC-48UFD-1/NPL-4 complex in Caenorhabditis 
elegans led to a reduction in DNA synthesis and a replication checkpoint-dependent 
delay in S phase progression (Mouysset et al, 2008). This reduction in DNA synthesis 
for cells with impaired p97 is most likely due to inhibited degradation of the replication 
licensing factor CDT1 at the beginning of DNA replication which was shown to be 
conserved in mammalian cells (Franz et al, 2011; Raman et al, 2011). Additionally, in 
yeast p97 mediates the disassembly of the CMG helicase in S phase (Maric et al, 
2014; Moreno et al, 2014). However, this p97-dependent process is unlikely to 
contribute to the phenotype of reduced DNA synthesis, since this disassembly only 
occurs after replication termination. 
In Caenorhabditis elegans, the cofactors shown to be involved in CDT-1 degradation 
are UFD-1, NPL-4, and the novel p97 cofactor UBXN-3 (FAF1 in humans; Franz et al, 
2011; Franz et al, 2016). Inactivation of CDC-48/p97 or one of these cofactors 
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stabilized CDT-1 on chromatin, resulting in replication stress. This replication stress 
caused a marked decrease in replication fork velocity, an increased number of stalled 
forks, and newly fired origins (Franz et al, 2011; Franz et al, 2016). Furthermore, the 
involvement of Ufd1 and FAF1 in CDT1 degradation were shown to be conserved in 
human cells (Raman et al, 2011; Franz et al, 2016). 
However, in our setting we only observed a decrease in DNA synthesis for p97 and, 
intriguingly, for DVC1 which can most likely be explained by its involvement in TLS. 
Cells are constantly exposed to genotoxic insults which can cause DNA damage in 
form of base damage or DNA-protein crosslinks leading to TLS, meaning that TLS is 
activated even under unchallenged conditions. What remains unclear is if the reduction 
in DNA synthesis upon knockdown of p97 or DVC1 is due to a decreased number of 
origins of replication firing or to a decreased replication fork velocity as observed in 
Caenorhabditis elegans. 
 
A few years ago, our laboratory found that depletion of Ufd1 or Npl4 leads to 
chromosome segregation errors during mitosis (Dobrynin et al, 2011). So far, these 
defects in mitosis have been linked only to the mitotic function of p97Ufd1-Npl4 in 
antagonizing Aurora B which mediates the bipolar attachment of the mitotic spindle to 
the centromeres of the chromosomes. However, over the last decade p97 has been 
associated with functions in S phase, including S phase progression, CDT1 destruction 
at the beginning of DNA replication, and release of the CMG helicase at the end of 
DNA replication (Mouysset et al, 2008; Franz et al, 2011; Raman et al, 2011; Maric et 
al, 2014; Maculins et al, 2015; Franz et al, 2016). Additionally, we could prove that a 
non-functional p97Ufd1-Npl4 complex weakens the G2/M checkpoint (Riemer et al, 2014). 
All these findings led us to ask, if the severe segregation defects observed in Ufd1-
Npl4-depleted cells exclusively arise from compromised mitotic functions of p97Ufd1-Npl4 
or if they additionally originate from replication-associated damage carried over into 
mitosis due to the G2/M checkpoint override. 
By staining with the centromere marker CREST, we could distinguish errors of mitotic 
or pre-mitotic origin (Burrell et al, 2013). Lagging chromosomes in anaphase bearing a 
centromere were considered to originate from improper spindle attachment and 
therefore defects in mitotic functions, whereas acentric chromosomal fragments and 
chromosome bridges in anaphase were considered to result from pre-mitotic defects. 
Notably, anaphase bridges usually result from improper fusion of DNA strands with a 
DSB (Geigl et al, 2008). However, they can also arise from erroneous spindle 
attachment (Maia et al, 2012). 
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Our results revealed that replication stress in form of APH, an inhibitor of DNA 
polymerases α and δ, led to an increase in segregation errors in mitosis that arise from 
S phase defects after depletion of p97, Ufd1, Npl4, or DVC1. This increase in mitotic 
defects of pre-mitotic origin indicates unrepaired or incompletely replicated DNA, 
providing evidence that p97Ufd1-Npl4 and DVC1 suppress chromosomal instability that 
stems from defects in interphase. 
Further experiments in our group confirmed that cells depleted of Ufd1 or Npl4 enter 
mitosis despite DNA damage (Riemer et al, 2014). For instance, Ufd1- or Npl4-
depleted cells display an increase in γH2AX foci on the mitotic chromatin after IR. 
Moreover, we observed a drastically elevated occasion of chromosomal aberrations in 
metaphase spreads following IR in cells depleted of Ufd1 or Npl4. 
Consistent with our results, in Caenorhabditis elegans, it was shown that in embryos 
depleted of CDC-48, UFD-1 or NPL-4 separating chromatids often remained connected 
by chromosomal bridges, indicating replication defects (Mouysset et al, 2008). 
However, the underlying mechanism was not identified. Yet, this indicates a conserved 
role for p97Ufd1-Npl4 in S phase. 
Intriguingly, depletion of the p97 adaptor DVC1 also led to a prominent increase in 
mitotic segregation errors with pre-mitotic origin after replication stress. Since DVC1 is 
involved in TLS, it is not surprising that cells lacking DVC1 display more DNA damage 
(Centore et al, 2012; Davis et al, 2012; Ghosal et al, 2012; Juhasz et al, 2012; Machida 
et al, 2012; Mosbech et al, 2012; Kim et al, 2013). However, it remains unclear, how 
cells depleted of DVC1 override the G2/M checkpoint so that this damage manifests in 
mitosis. 
 
The contribution of replication stress to chromosomal instability in cells with impaired 
p97 function raised the question, if p97 and its cofactors are crucial for the survival of 
human tumor cells after replication stress. To address this issue, we depleted HeLa 
cells of p97 or its cofactors Ufd1, Npl4, UBXD7, or DVC1 and examined cell viability 
with an MTS assay after additional application of replication stress. In our setting, we 
applied replication stress by treatment with the DNA crosslinker cisplatin or the 
topoisomerase II inhibitor doxorubicin that are genotoxic chemotherapeutics. 
Cytotoxicity of cisplatin and doxorubicin was significantly elevated in cells depleted of 
p97. Depletion of Ufd1 or Npl4 provoked a slightly increased sensitivity to cisplatin at 
high concentrations and a significantly increased sensitivity to doxorubicin, albeit not as 
pronounced as in the case of p97. In contrast, knockdown of UBXD7 or DVC1 did not 
affect cell viability after replication stress. Notably, depletion of p97 or Npl4 resulted in 
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a significant reduction in cell proliferation over control cells in unchallenged cells in 
contrast to depletion of the other analyzed proteins. 
Additionally, we examined if p97 inhibition was able to sensitize human cancer cells to 
the genotoxic chemotherapeutic drugs cisplatin or doxorubicin. Only upon p97 
inhibition with the potent inhibitor NMS-873, we observed significant synthetic lethality 
with doxorubicin treatment, although to a lesser extent than upon p97 depletion. It 
remains unclear if these observations are due to weak inhibition of the p97 ATPase 
activity or whether the absence of p97 itself causes sensitization in depleted cells. 
Similar to our observations, Puumalainen and colleagues revealed a hypersensitivity to 
UV light of p97-depleted cells in a colony formation assay (Puumalainen et al, 2014). 
Consistently, p97 inhibition with DBeQ significantly decreased cell survival after UV 
irradiation in an MTT assay (He et al, 2016). UV light induces the formation of CPDs 
and 6-4PPs that are mainly repaired by NER, whereas cisplatin-induced base 
crosslinks activate three different repair or tolerance pathways, namely HR, NER, and 
TLS. 
In cells with compromised p97 function, cell viability after UV damage is aggravated 
due to impaired DNA repair after UV irradiation because p97 is involved in the repair of 
UV lesions. In GG-NER, it targets the DNA damage sensors XPC and DDB2, and in 
TC-NER, it targets CSB (Puumalainen et al, 2014; He et al, 2016). Reduced survival of 
p97-depleted cells after cisplatin can be explained by the role of p97 in HR, NER, and 
TLS, even though the underlying mechanism for compromised HR and TLS in p97-
deficient cells remains elusive. Surprisingly, knockdown of UBXD7 or DVC1 had no 
influence on cell viability after cisplatin treatment, although UBXD7 and DVC1 have 
been linked to NER and TLS, respectively. In contrast, depletion of the two p97 adaptor 
proteins Ufd1 or Npl4 caused an elevated sensitivity to cisplatin. This stronger effect of 
Ufd1 or Npl4 depletion compared to UBXD7 or DVC1 depletion might be due to the 
involvement of Ufd1-Npl4 in more than only one of the three repair/tolerance pathways 
required to cope with cisplatin-induced DNA crosslinks. So far, for the Ufd1-Npl4 
adaptor only the participation in NER is clearly confirmed (Verma et al, 2011; 
Puumalainen et al, 2014; He et al, 2016). However, its involvement in TLS is 
controversial (Davis et al, 2012; Mosbech et al, 2012) and for HR there are no data yet. 
In Caenorhabditis elegans, the synergistic effect of impeded CDC-48, UFD-1, or NPL-4 
combined with sublethal doses of another replication stress, the replication blocking 
agent hydroxyurea, was analyzed. Hydroxyurea inhibits the ribonucleotide reductase 
and thus decreases the production of dNTPs. In worms, downregulation of CDC-48, 
UFD-1, or NPL-4 led to an increased sensitivity towards hydroxyurea, resulting in 
embryonic lethality and sterile worms (Mouysset et al, 2008). This phenotype was 
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accompanied by the activation of the DNA replication checkpoint kinases ATL-1/ATR 
and CHK-1/Chk1 (Mouysset et al, 2008). Additionally, co-depletion of CDC-48 and 
UBXN-3, the worm ortholog of FAF1, potently impaired embryonic viability in 
Caenorhabditis elegans and this was further aggravated upon hydroxyurea treatment 
(Franz et al, 2016). This shows that the importance of p97, Ufd1, and Npl4 for survival 
under stress conditions is conserved.  
Furthermore, Meerang and colleagues investigated the survival of human tumor cells 
after IR by a colony formation assay (Meerang et al, 2011). IR mainly induces DSBs, 
similar to doxorubicin. Doxorubicin intercalates into DNA and is able to covalently link 
topoisomerase II to DNA, which results in a DSB when encountered by a replication 
fork in the following round of replication (Li & Baker, 2000). The results of the colony 
formation assay showed a decreased survival after IR and additional depletion of p97, 
Ufd1, or Npl4 or after p97 inactivation by the expression of p97EQ (Meerang et al, 
2011). p97EQ is a dominant negative p97 variant, where the conserved glutamate in 
the Walker B motif of the D2 domain is changed to glutamine, resulting in an ATPase-
deficient p97 mutant able to bind, but unable to release substrates (DeLaBarre & 
Brunger, 2003). Similar to the observations by Meerang and colleagues, we monitored 
decreased cell viability upon depletion of p97, Ufd1, or Npl4 and additional treatment 
with doxorubicin. Impeded survival after IR or doxorubicin can be explained by the 
relevance of p97Ufd1-Npl4 for DSB repair, although the exact role of p97 in DSB repair is 
unclear. However, impairment of p97 activity reduced HR and NHEJ (Meerang et al, 
2011). Moreover, there is evidence that p97 is involved in the removal of L3MBTL1 
from H4K20me2 at DSBs allowing for binding of 53BP1 to the newly exposed histone 
methyl marks (Acs et al, 2011). 
In Saccharomyces cerevisiae, seven UBX-containing genes were identified. Deletion of 
any of these genes results in viable yeast cells. However, yeast cells lacking multiple 
UBX proteins show severe phenotypes including cell death. These observations 
suggest that the single UBX proteins have critical, but overlapping functions 
(Decottignies et al, 2004; Schuberth et al, 2004; Buchberger, 2013). Similarly, in our 
experiments knockdown of p97 or Npl4 already caused a significant reduction in cell 
survival without further replication stress, while knockdown of the other analyzed 
cofactors did not. This observation stresses the importance of p97 and Npl4 for a 
myriad of pathways that are critical for cell survival, including cell cycle-related 
functions and functions in the protein quality control. 
 
Taken together, there is evidence that p97 plays a role in DNA replication and the 
replication stress response. After p97 depletion, we observe reduced DNA synthesis, 
Discussion 
82 
 
DNA damage from S phase manifesting in mitosis, decreased cell survival and 
synthetic lethality with genotoxic agents. However, the exact function of p97 in 
replication and the replication stress response remains elusive. 
 
3.3 The role of UBXD7 
In the last part of this thesis, we aimed to investigate the novel p97 cofactor UBXD7 
that was linked to DNA-related functions of p97. First, we analyzed the role of UBXD7 
for diverse p97 substrate proteins. As a member of the family of UBA-UBX proteins, 
UBXD7 is able to bind to CRLs (Alexandru et al, 2008). Via its unique UIM domain, it 
binds to active, neddylated CRLs (Bandau et al, 2012; den Besten et al, 2012). 
Thereby, it directly links p97 to ubiquitin ligases. Moreover, p97-UBXD7 complexes 
bind to substrate proteins. So far, all identified UBXD7 substrates are nuclear proteins. 
These substrates include the CDC25A phosphatase which was identified as a 
substrate in this study, the hypoxia-inducible transcription factor HIF1α, the UV 
damage sensor DDB2, CSB which is required for the proteolytic release of RNA 
polymerase II, and, in yeast, the largest subunit of RNA polymerase II, Rpb1 
(Alexandru et al, 2008; Verma et al, 2011; Puumalainen et al, 2014; He et al, 2016). 
However, the direct link of UBXD7 to p97 and to CRLs raised the question if UBXD7 is 
generally involved in CRL- and p97-dependent degradation both in the nucleus and in 
the cytoplasm. 
To address this issue, we examined if UBXD7 participates in the turnover of a CRL- 
and p97-dependent substrate in the cytoplasm. For this purpose, we surveyed 
degradation of the cytosolic protein IκBα. Cytokine-induction prompts the CRL SCFβTrCP 
to ubiquitylate IκBα, leading to its proteasomal degradation with the help of p97Ufd1-Npl4 
(Li et al, 2014). Thus, IκBα is a cytosolic substrate of a CRL and p97. Immunoblot 
analysis revealed that, in contrast to p97Ufd1-Npl4, UBXD7 is not involved IκBα 
degradation after TNFα induction (Fig. 3.1). Therefore, this indicates that UBXD7 is not 
required for the degradation of all CRL and p97 substrates. The finding that IκBα 
turnover is unaffected by UBXD7 is in line with the current view of UBXD7 acting 
exclusively in the nucleus. However, while two studies found overexpressed Flag-
UBXD7 and GFP-UBXD7, respectively, localizing strictly to the nuclei of HeLa cells, a 
commercially available antibody from Millipore shows endogenous UBXD7 in the 
cytosol with the images being provided from the Alexandru group (Bandau et al, 2012; 
Raman et al, 2015). For this reason, we cannot exclude further functions of UBXD7 in 
the cytoplasm. Yet, Raman and colleagues performed systematic proteomics of the 
p97-UBXD adaptor network and identified several binding partners of UBXD7 that all 
localize to the nucleus (Raman et al, 2015). These binding partners include proteins 
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associated with TC-NER, other DDR proteins, and CRL components. It is unclear, if 
UBXD7 has a cytosolic counterpart overtaking its function in connecting p97 to CRLs in 
the cytoplasm. 
 
 
Figure 3.1: UBXD7 plays a role in CDC25A degradation, but not in IκBα degradation. 
CDC25A and IκBα are both ubiquitylated by SCF
βTrCP
. After ubiquitylation, p97
Ufd1-Npl4
 facilitates 
proteasomal degradation of both molecules. However, while UBXD7 is involved in CDC25A 
degradation, IκBα degradation is independent of UBXD7. Pr: proteasome. 
 
In addition to studies on UBXD7 targets, we aimed to elucidate the relevance of the 
individual UBXD7 domains for its function. UBXD7 comprises an N-terminal ubiquitin-
associated UBA domain, an ubiquitin-associating UAS domain, an ubiquitin-interacting 
motif (UIM) and a C-terminal UBX domain. The UBA domain is able to associate with 
ubiquitin, whereas the function of the UAS domain is unclear. The already mentioned 
UIM binds directly to the NEDD8 moiety of neddylated CRLs (Bandau et al, 2012; den 
Besten et al, 2012). However, it can also bind ubiquitin (Fisher et al, 2003). Interaction 
with p97 is mediated by the UBX domain.  
To elucidate the contribution of the individual UBXD7 domains to its function, a detailed 
structure-function analysis of UBXD7-mediated degradation was performed. For this 
purpose, UBXD7 deletion mutants lacking the UBA, UAS or UIM domain, as well as a 
UBXD7 variant with a point-mutation known to abrogate p97-binding (P459G) were 
generated (Bandau et al, 2012). As the substrate for this experiment, the robust 
UBXD7 substrate DDB2 was chosen (Puumalainen et al, 2014). The UBXD7 variants 
were assayed for their ability to rescue DDB2 degradation, which is strictly UBXD7-
dependent. We could show that the ΔUBA variant was able to almost completely 
rescue DDB2 degradation, whereas the ΔUAS mutant displayed only a partial rescue. 
In contrast, UBXD7_ΔUIM and UBXD7_P459G did not restore DDB2 degradation. 
These observations indicate that binding to neddylated CRLs via the UIM and binding 
to p97 via the UBX are essential for UBXD7 function, whereas the ability to directly 
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bind ubiquitylated substrates via the UBA is dispensable. The partial rescue of the UAS 
is difficult to explain, since its function is still unknown.  
Bandau and colleagues found that a UBXD7 mutant lacking the UAS domain was able 
to interact with ubiquitin, p97 and CUL2 (Bandau et al, 2012). In contrast, den Besten 
and colleagues demonstrated that in vivo the ΔUAS variant is defective in CUL2-
binding, which they did not observe in vitro (den Besten et al, 2012). Since we showed 
that the UBXD7_ΔUAS variant was only partially functional, this indicates that the UAS 
has a function in substrate degradation which still has to be explored. 
The effect of the expression of the UBXD7_ΔUIM variant on the UBXD7 substrate 
HIF1α, which is ubiquitylated by CRL2 prior to proteasomal degradation, has already 
been investigated (Bandau et al, 2012). Previous experiments revealed that HIF1α 
levels decrease upon UBXD7 knockdown and increase upon UBXD7 overexpression, 
while the opposite is observed for knockdown or overexpression of p97 (Alexandru et 
al, 2008). As an explanation for this apparent paradox, it was proposed that lack of 
UBXD7 abolishes p97 recruitment to HIF1α, but allows the engagement of other 
proteasome targeting factors or the proteasome itself. Additionally, UBXD7 binding 
protects HIF1α from the association of these other proteasome targeting factors in p97-
depleted cells. However, HIF1α accumulation upon UBXD7 overexpression was 
dependent on the UIM, as overexpression of the ΔUIM mutant did not affect HIF1α 
levels (Bandau et al, 2012). They could show that deletion of the UIM abolished the 
interaction with CUL2 and led to a complete loss of binding to non- or oligo-
ubiquitylated HIF1α. Nonetheless, the ΔUIM mutant was still able to associate with 
poly-ubiquitylated HIF1α, most likely via the UBA domain. Consistently, deletion of the 
UIM led to a loss of function of UBXD7 in our experimental setting. 
Furthermore, we could show that DDB2 turnover is independent of the UBA domain of 
UBXD7. Thus, direct binding of UBXD7 to ubiquitylated DDB2 via the UBA is 
dispensable. However, UBXD7_ΔUBA could still bind ubiquitin through its UIM. 
Additionally, UBXD7 indirectly interacts with the ubiquitylated substrate via its 
association with the CRL and p97. Alexandru and colleagues proposed that substrate 
binding to UBXD7 precedes the recruitment of p97Ufd1-Npl4 and may even be a 
prerequisite for it (Alexandru et al, 2008). The basis for their suggestion was the 
observation that binding of UBXD7 to the substrate and the E3 ubiquitin ligase does not 
require p97Ufd1-Npl4, whereas the interaction of p97Ufd1-Npl4 with the substrate and E3 
ubiquitin ligase depends on UBXD7. For this reason, they proposed a model that the 
UBA and UBX domains of UBXD7 bind intra- or intermolecularly, thereby maintaining 
UBXD7 in an inactive state. Only after UBXD7 binds to a ubiquitylated substrate via the 
UBA domain, the UBX domain would be set free to recruit the p97Npl4-Ufd1 complex. In 
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contrast to their opinion that UBXD7 directly binds to ubiquitylated substrates via its 
UBA domain, we suggest that UBXD7 is recruited to the ubiquitylated substrate by its 
UIM associating with the neddylated CRL and therefore only indirectly interacts with the 
ubiquitylated substrate. 
In a second step, p97Ufd1-Npl4 is recruited to the ubiquitylated substrate. He and 
colleagues showed that p97 recruitment to sites of UV lesion is independent of UBXD7, 
indicating that p97 and UBXD7 are recruited to ubiquitin conjugates independent of 
each other (He et al, 2016). In contrast, p97 recruitment to sites of UV lesion was 
shown to depend on Ufd1 and Npl4 (Puumalainen et al, 2014). This indicates that p97 
is recruited to ubiquitylated substrates via the ubiquitin binding domains of its ubiquitin 
adaptors. In the case of DDB2, this means that p97Ufd1-Npl4 binds to ubiquitylated DDB2 
via the UT3 and NZF domains of Ufd1 and Npl4, respectively. Consistent with this 
hypothesis, the UBA domain of UBXD7 is not critical for substrate degradation. 
However, it might support the interaction with the ubiquitylated substrate. 
The UBXD7 interaction with p97 is mediated by its UBX domain and this interaction is 
essential for UBXD7 function. Surprisingly, a defect in p97-binding was shown to 
additionally impair ubiquitin-binding, whereas CUL2 interaction was largely unaffected 
(Bandau et al, 2008). Therefore, this indicates that binding to ubiquitylated substrates 
does neither occur directly via the UBA domain, nor indirectly via the CRL. In contrast, 
binding to ubiquitylated substrates would depend on p97-binding to the ubiquitylated 
substrate via Ufd1-Npl4. 
Taken together, these data show that further experiments are required to clarify the 
contribution of the single UBXD7 domains to its function. 
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4 Material and Methods 
4.1 Molecular biological methods 
4.1.1 Cloning strategy 
For the generation of a reporter cell line inducibly expressing GFP-CDC25A, GFP-
CDC25A had to be cloned into the vector pcDNA5.0/FRT/TO (Thermo Scientific). We 
received CDC25A/pOPINE as a gift from Dr. Christian Ottmann, Chemical Genomics 
Centre, Dortmund, Germany. First, CDC25A was cloned from pOPINE into the vector 
pEGFP-C1 (Clontech). For this purpose, the coding sequence of CDC25A was 
amplified by polymerase chain reaction (PCR) with DNA primers carrying KpnI and 
BamHI restriction sites at the 5’- and 3’-end, respectively. After that, GFP-CDC25A was 
cloned from the GFP-CDC25A/pEGFP-C1 construct into the plasmid backbone 
pcDNA5.0/FRT/TO by PCR amplification of GFP-CDC25A with DNA primers 
introducing novel EcoRV and NotI restriction sites at the 5’- and 3’-end, respectively. 
 
4.1.2 Polymerase chain reaction 
The DNA primers for the PCR were designed with 15 to 20 nucleotides binding to the 
target sequence and one to three nucleotides overhang behind the restriction site. The 
length of the overhang was chosen according to the manufacturer’s recommendations 
for the enzyme cutting the restriction site. The enzymes were purchased from New 
England Biolabs (NEB). The DNA primers were ordered from Metabion. The primer 
sequences are listed in Table 4.1. 
 
Table 4.1: DNA primers used for PCR. 
Target Orientation Sequence Tannealing 
CDC25A forward ATGGGTACCGAACTGGGCCCGGAGC 68 °C 
 reverse TGAGGATCCTTAGAGCTTCTTCAGACGAC 57 °C 
GFP-CDC25A forward CGATATCGCCACCATGCTGAGC 53 °C 
 reverse AGCGGCCGCTTAGAGCTTCTTCAGACGAC 52 °C 
The sequences of the DNA primers are given in 5’ to 3’ direction. The restriction sites are 
highlighted in red. 
 
The PCR was carried out in 50 µl reactions, with the following components mixed in 
0.2 ml PCR reaction tubes on ice: 
10 µl 5x Phusion HF buffer  
2 µl 10 mM dNTP mix (Invitrogen) 
2 µl DNA-primer forward (100 pmol) 
2 µl DNA-primer reverse (100 pmol) 
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10 ng DNA template 
0.5 µl Phusion DNA Polymerase (2 U/µl; Thermo Scientific) 
ad 50 µl ddH2O 
The target sequence was amplified with a TPersonal thermocycler (Biometra) using the 
standard PCR protocol described in Table 4.2. 
 
Table 4.2: Standard PCR protocol. 
 Temperature Time  
First denaturation 98 °C 20 s  
Denaturation 98 °C 10 s  
Annealing 53/57 °C 30 s      27 cycles 
Elongation 72 °C 1 min  
Final elongation 72 °C 9 min  
 
The annealing temperature was chosen according to the sequence of the DNA primers 
used for the PCR. The correct amplification of the PCR product was verified by 
agarose gel electrophoresis.  
 
4.1.3 Agarose gel electrophoresis 
The PCR mixture was mixed with 5x DNA loading buffer (NEB) and separated on a 1% 
TAE agarose gel supplemented with GelRed nucleic acid gel stain (Biotium). A 1 kb 
DNA ladder (NEB) served as a marker for size. Agarose gels were run in a chamber 
filled with TAE buffer for 1 h at a constant voltage of 100 V with the peQPOWER 300 
power supply (Peqlab). After gel electrophoresis, the correct PCR product was cut out 
of the gel and purified with a PCR clean-up gel extraction kit (Macherey-Nagel). Then, 
the DNA concentration was determined photometrically with a BioPhotometer D30 
(Eppendorf). 
 
4.1.4 Restriction 
The purified PCR product and the target backbone were cut with restriction 
endonucleases that target the newly introduced restriction sites of the PCR product. 
The restriction with two different enzymes was either carried out simultaneously or 
consecutively, depending on the manufacturer’s recommendations for the respective 
restriction enzymes used. All restriction endonucleases were purchased from NEB. 
The restriction was carried out for 1 h at 37 °C in 10 µl reactions containing the 
following components: 
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1 µg DNA 
1 µl 10x NEB buffer (compatible to the enzyme used) 
1 µl BSA  
0.4 µl restriction enzyme (NEB) 
ad 10 µl ddH2O 
After restriction, the mixtures were purified using a NucleoSpin Extract II Kit (Macherey-
Nagel). 
 
4.1.5 Ligation 
To ligate the digested DNA fragment into the target vector, the digested vector was 
incubated with three times excess of the DNA insert. The ligation was carried out 
overnight at 16 °C in 20 µl reactions containing the following components: 
150 ng DNA insert 
50 ng plasmid vector 
2 µl 10x ligase buffer 
0.5 µl T4 DNA ligase (NEB) 
ad 20 µl ddH2O 
 
4.1.6 Bacterial transformation 
Chemically competent bacteria were transformed with the ligated plasmid constructs by 
heat shock. The bacteria used for transformation were Escherichia coli bacteria of the 
strain DH5α (genotype: fhuA2 lac(del)U169 phoA glnV44 Φ80' lacZ(del)M15 gyrA96 
recA1 relA1 endA1 thi-1 hsdR17). 
For transformation, 50 µl of DH5α bacteria was incubated with 10 µl of the ligation 
reaction for 20 min on ice. Then, the bacteria were placed in a 42 °C-water bath for 
1 min and subsequently incubated on ice for 10 min. Bacteria transformed with plasmid 
DNA resistant against kanamycin (in this study the backbone pEGFP-C1) were 
incubated with 200 µl SOC medium for 30 min at 37 °C. After that, the bacteria were 
grown overnight at 37 °C on LB agar plates containing 50 µg/ml ampicillin (Diagonal) or 
50 µg/ml kanamycin (Diagonal), depending on the resistance of the DNA plasmid. 
 
4.1.7 Plasmid preparation (Mini prep) 
Single colonies of the bacteria were picked and incubated with 2 ml LB medium 
supplemented with 50 µg/ml ampicillin or 50 µg/ml kanamycin overnight at 37 °C. Then, 
the plasmid DNA was purified using a Plasmid DNA Purification Kit (Macherey-Nagel). 
Insertion of the target fragment into the vector was confirmed by control restrictions. 
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4.1.8 Sequencing 
The correct insertion of the target fragment into the vector was confirmed by 
sequencing. Sequencing reactions were carried out by GATC Biotech. 
 
4.2 Cell culture 
Cells were maintained at 37 °C and 5% CO2. Dulbecco’s Modified Eagle Medium 
(DMEM; PAN) supplemented with 10% fetal bovine serum (FBS; PAN, Lot No.: 
P280209) and 1% penicillin/streptomycin (PAN) was used as a cell culture medium for 
HeLa Kyoto or U2OS cells. U2OS-FRT-TO cells inducibly expressing GFP-CDC25A 
were maintained in DMEM supplemented with 10% tetracycline-free FBS (PAN, Lot 
No.: P040214TC), 1% penicillin/streptomycin, 130 µg/ml hygromycin B (PAN) and 
4 µg/ml blasticidin S (Gibco). Expression of GFP-CDC25A was induced with 1 µg/ml 
doxycycline (Diagonal). 
 
4.2.1 Generation of a GFP-CDC25A reporter cell line 
To generate a reporter cell line inducibly expressing GFP-CDC25A, U2OS-FRT-TO 
cells carrying a single integrated FRT (Flp recombination target) site and a stably 
integrated tetracycline (Tet) repressor were used. The U2OS-FRT-TO cells were 
cultured in DMEM supplemented with 10% tetracycline-free FBS, 1% 
penicillin/streptomycin, 50 µg/ml zeocin (Invitrogen) and 4 µg/ml blasticidin S (Gibco). 
The cells were co-transfected with GFP-CDC25A/pcDNA5.0-FRT-TO and the pOG44 
Flp-recombinase plasmid (Invitrogen) in a 1:9 ratio to achieve integration into the FRT 
site. Plasmids were transfected using Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s instructions. After 24 h, cells were cultured in DMEM selection medium 
containing 10% tetracycline-free FBS, 1% penicillin/streptomycin, 130 µg/ml 
hygromycin B and 4 µg/ml blasticidin S, until single cell colonies were detectable. 
Single clones were picked and cultured separately. 
 
4.2.2 RNA interference 
RNA interference (RNAi) was carried out by transfection of cells with siRNA duplexes 
using the Lipofectamine RNAiMAX transfection reagent (Invitrogen). Cells were either 
seeded one day in advance (forward transfection) or at the same time as RNAi 
transfection (reverse transfection). The cells were transfected at 30 to 50% confluence 
with a final concentration of 10 nM siRNA. Transfection with Lipofectamine RNAiMAX 
transfection reagent was performed according to the manufacturer’s instructions. All 
siRNAs were purchased from Microsynth. siRNA sequences are listed in Table 4.3. 
RNAi transfected cells were analyzed 48 or 72 h after transfection. 
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For a reverse transfection in a 6-well plate format, 1.2 µl of a 20 mM siRNA stock 
solution was diluted in 250 µl Opti-MEM I (Gibco). Separately, 2.4 µl of the 
Lipofectamine RNAiMAX transfection reagent was diluted in 250 µl Opti-MEM I, mixed 
briefly and added to the diluted siRNA. After 20 min incubation at room temperature, 
the transfection mixture was added to the wells, before the cells were seeded. For 
transfection in 12-well plates, half the volumes were used. 
 
Table 4.3: siRNA oligonucleotides used for depletion. 
Target Oligo Sequence Source 
- siCtrl UUCUCCGAACGUGUCACGUTT  Ritz et al., 2011 
βTrCP1/2 siβTrCP1/2 GUGGAAUUUGUGGAACAUCTT  Busino et al., 2003 
Chk1 siChk1 S1 AAGGGATAACCTCAAAATCTCTT  Carrassa et al., 2009 
DVC1 siDVC1 S1 ACGAUGAGGUGGAUGAGUATT  Mosbech et al., 2012 
 siDVC1 S2 UCAAGUACCACCUGUAUUATT  Mosbech et al., 2012 
Luciferase siluc CGUACGCGGAAUACUUCGATT  Microsynth 
Npl4 siNpl4 S1 CGUGGUGGAGGAUGAGAUUTT  Dobrynin et al., 2011 
 siNpl4 S6 CGGAAGGUUGGCUGGAUAUUUTT Li et al., 2014 
p97 sip97 S2 AACAGCCAUUCUCAAACAGAATT  Qiagen, HS_VCP_7 
 sip97 S6 GGAGUUCAAAGUGGUGGAAACAGAUTT  Invitrogen, 
HSS111264 
PSMB5 siPSMB5 UUCUCCGAACGUGUCACGUTT Li et al., 2014 
Ufd1 siUfd1 S1 GGGCUACAAAGAACCCGAATT  Microsynth 
 siUfd1 S2 GUGGCCACCUACUCCAAAUTT  Dobrynin et al., 2011 
 siUfd1 S3 CUACAAAGAACCCGAAAGATT  Microsynth 
 siUfd1 S4 ACAAAGAACCCGAAAGACATT  Microsynth 
 siUfd1 S5 CUGGGCUACAAAGAACCCGAA  Qiagen, UFD1_L 
 siUfd1 S6 CCCAAUCAAGCCUGGAGAUAUTT Li et al., 2014 
UBXD1 siUBXD1 CCAGGUGAGAAAGGAACUUTT Ritz et al., 2011 
UBXD7 siUBXD7 
S1 
CAGCUUGAAAGGAGUGUUUTT Qiagen, 
Hs_KIAA0794_2 
UBXD8 siUBXD8 GAAGUUAUUUCACUAAUAATT Suzuki et al., 2012 
 
4.2.3 Plasmid transfection 
Plasmids were transfected using polyethylenimine (PEI). Reaction mixtures containing 
2 µl PEI (10 mM stock, pH 7.0, Sigma), 2 µg DNA and 50 µl PBS (PAN) were 
incubated for 15 min and added dropwise onto cells with 60-80% confluency. Plasmids 
were expressed for 24 h. 
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4.2.4 Pharmacological treatments 
To block protein synthesis, either 50 µg/ml was added to the cells. p97 function was 
inhibited by treatment with DBeQ (Sigma-Aldrich or BioCat), NMS-859 (Sigma-Aldrich), 
NMS-873 (Sigma-Aldrich), I8, I5, or I1. An information embargo bans us from revealing 
the full names and structures of the unpublished inhibitors I8, I5, and I1, which we 
received for testing. To block proteasomal degradation, cells were treated with 10 µM 
MG132 (Merck-Millipore). Replication stress was induced by treatment with either 
cisplatin (Teva), doxorubicin (Diagonal), or aphidicolin (Sigma-Aldrich). Since the p97 
inhibitors and aphidicolin were dissolved in dimethyl sulfoxide (DMSO), DMSO served 
as control. 
 
4.2.5 Irradiation 
UV irradiation was carried out by use of the CL-1000 Ultraviolet Crosslinker (UVP). 
Cells were exposed to IR in a Cabinet X-Ray System (Philips MCN 165; 3 mm Al filter; 
130 kV, 16 mA; dose-rate 1.2 Gy/min).  
 
4.3 Cell-based assays 
4.3.1 BrdU flow cytometry assay 
Approximately 1 million HeLa cells were incubated with 30 µM BrdU for 15 min at 37 °C 
to pulse-label the cells. Then, the cells were washed twice with PBS, treated with 
trypsin and collected in reaction tubes. After cell counting, the cells were centrifuged for 
5 min at 1500 rpm, the supernatant was removed and the cells were fixed with 1 ml 
70% cold ethanol. The cells were again centrifuged for 5 min at 1500 rpm, the 
supernatant was removed and the cells were washed with 1 ml 0.9% NaCl. After that, 
the cells were again centrifuged for 5 min at 1500 rpm and the supernatant was 
removed. Next, the cells were incubated with 1 ml cold pepsin/HCl for 10 min at 37 °C. 
Subsequently, 3 ml ice-cold 0.9% NaCl was added and the suspension was centrifuged 
for 5 min at 1500 rpm and the supernatant was removed. Next, the pellet was 
resuspended in 1 ml 2 M HCl and incubated for 20 to 30 min at room temperature. 
Then, 3 ml 0.9% NaCl was added, the suspension was centrifuged for 5 min at 
1500 rpm and the supernatant was removed. After that, the pellet was resuspended in 
1 ml PBS-T, the suspension was centrifuged for 5 min at 1500 rpm and the supernatant 
was removed. Subsequently, the cells were incubated with 250 µl primary anti-BrdU 
antibody (BD, 347580) diluted 1:50 in PBS-T for 30 min. After another centrifugation 
step at 1500 rpm for 5 min, unbound primary antibody was removed by washing with 
1 ml PBS-T-BSA (1%, Albumin fraction V, Applichem), the suspension was centrifuged 
for 5 min at 1500 rpm and the supernatant was removed. Then, the cells were 
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incubated with 250 µl secondary Alexa Fluor 488 goat anti-mouse antibody (Life 
Technologies, A-11029) diluted 1:200 in PBS-T-BSA (1%) for 30 min, the suspension 
was centrifuged at 1500 rpm for 5 min and the supernatant was removed. Next, the 
pellet was washed with 1 ml PBS-T-BSA (1%), the suspension was centrifuged for 
5 min at 1500 rpm and the supernatant was removed. Finally, the pellet was 
resuspended in 1 ml PBS containing 25 µg/ml propidium iodide (Sigma) and 50 µg/ml 
RNAse A (Roche) and incubated for 15 min at 37 °C. After that, the suspension was 
analyzed by flow cytometry with a FACSCalibur (BD Biosciences). The measured 
intensities were evaluated with Kaluza Flow Cytometry Analysis software (Beckman 
Coulter). The Alexa Fluor 488 intensities were plotted against the PI intensities and the 
percentage of BrdU positive cells was determined. Additionally, to visualize the cell 
cycle distribution the counts were plotted against the PI intensities in histograms. 
 
4.3.2 Radioresistant DNA synthesis assay 
Approximately 0.1 to 0.15 million HeLa cells were cultured for 48 h in 25 cm3 cell 
culture flasks and were irradiated with 10 Gy IR at 37 °C. Subsequently, they were 
brought to a warm room with a constant temperature of 37 °C and 5% CO2. After 
specific time points, the cell culture medium was removed and 2 ml of prewarmed 
radioactive medium containing 0.3 µCi/ml 3H-thymidine was added to the flasks for 
15 min (pulse-labeling). Then, the radioactive medium was removed and the cells were 
washed with 2 ml cold PBS. After that, 1 ml trypsin was added to the cells and 
incubated for 3 min in the warm room. The cells were collected with 4 ml DMEM 
supplemented with 10% FBS and 1% penicillin/streptomycin in 15 ml Falcon tubes 
already placed in ice-water. After cell counting, the samples were poured on separate 
GF/A glass microfiber filters and the medium was aspirated with a vacuum pump. 
Then, 15 ml 10% trichloric acid was added onto each filter, incubated briefly and 
aspirated. Finally, 15 ml ddH2O was added onto each filter, incubated briefly and 
aspirated. After that, each filter was placed into a separate scintillation vial and dried for 
a moment. Then, 0.5 ml 0.5 M NaOH was added into each vial. After incubation 
overnight at 65 °C, 0.5 ml 0.5 M HCl was added into each vial. Finally, 10 ml of liquid 
scintillation fluid was added into each vial, mixed briefly and 3H-activity was measured 
using a liquid scintillation counter. The RDS assay was performed together with Dr. 
Aashish Soni at the Institute for Medical Radiation Biology at the University Hospital, 
Essen, run by Prof. Dr. George Iliakis. 
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4.3.3 Cell viability assay 
The number of viable cells was determined with the CellTiter 96 AQueous One Solution 
Cell Proliferation Assay (Promega) in a 96-well plate format according to the 
manufacturer’s instructions. This assay is based on the reduction of the tetrazolium salt 
MTS to its insoluble formazan. The quantity of formazan product as measured by the 
amount of 490 nm absorbance with a 96-well plate reader (SpectraMax Plus 384, 
Molecular Devices) is directly proportional to the number of viable cells in culture. 
 
4.4 Biochemical methods 
4.4.1 Preparation of cell extracts 
For the preparation of cell extracts, all steps were carried out on ice to inhibit 
biochemical processes and preserve proteins. The cells were washed briefly with ice-
cold PBS, before they were lysed in 50 µl extraction buffer supplemented with protease 
inhibitor (Roche, Complete EDTA-free) and, if necessary, phosphatase inhibitor 
(Roche, PhosSTOP), or 10 mM N-ethylmaleimide (Sigma-Aldrich) and PR619 (Abcam) 
to inhibit deubiquitylation. Cells were scraped from the bottom of the dishes they were 
cultured in using a cell scraper (BD Falcon) and transferred to reaction tubes. After 
incubation on ice for 15 min, the cell extracts were centrifuged for 15 min at 13300 rpm 
and 4 °C to remove nuclei and heavy membrane fragments. Protein concentration was 
determined using a BCA assay (Interchim) in a 96-well plate format. Cell extracts were 
frozen in liquid nitrogen and stored at -80 °C. 
 
4.4.2 SDS-PAGE and Western blotting 
Protein samples from cell extracts were separated according to their size by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Protein samples with 
a protein content of 30 to 50 µg were prepared. Samples were supplemented with 6x 
SDS loading buffer and boiled at 95 °C for 10 min. PageRuler Prestained Protein 
Ladder (Thermo Scientific) served as a marker for protein size. All SDS gels were 
casted with 10% polyacrylamide, except for the investigation of IκBα degradation, 
where gradient gels containing 5-15% polyacrylamide were used. 10% SDS gels are 
given in Table 4.4. 
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Table 4.4: Recipes for SDS gels. 
 5% SDS gel 10% SDS gel 15% SDS gel 
H2O 5.37 ml 3.37 ml 1.37 ml 
1 M Tris pH 8.8 4.5 ml 4.5 ml 4.5 ml 
10% SDS 120 µl 120 µl 120 µl 
30% PAA 2 ml 4 ml 6 ml 
10% APS 60 µl 60 µl 60 µl 
TEMED 6 µl 6 µl 6 µl 
 
For SDS-PAGE, the Mini Trans-Blot system (Bio-Rad) was applied. The SDS running 
buffer contained Tris/glycine. Gels were run at a constant current of 20 mA per gel with 
an Electrophoresis Power Supply – EPS 601 (BioRad). To transfer the proteins from 
the gels onto nitrocellulose Hybond-C Extra (Amersham), either semi-dry or wet 
Western blotting was performed. For both, the gel was placed onto nitrocellulose and 
put between two double layers of Whatman filter paper, before the whole sandwich was 
soaked in blotting buffer. To avoid air bubbles, a plastic tube was rolled across the 
sandwich. For semi-dry blotting, the sandwich was put in a semi-dry Trans-blot SD 
transfer chamber (BioRad) and a constant current of 120 mA per gel was applied for 
55 min to transfer the proteins from the gel onto the membrane. For wet blotting, the 
sandwich was placed in Mini Trans-Blot chambers (BioRad), the chamber was 
completely filled with a wet blot buffer and a constant current of 300 mA per gel was 
applied for 3 h at 4 °C for protein transfer. The membranes were stained with Ponceau-
S dye to prove equal transfer. After destaining with 5% acetic acid and neutralization 
with PBS-T, the membranes were blocked in 10% fat free milk in PBS-T for 10 min. 
Membranes were washed three times for 5 min with PBS-T, before they were 
incubated with primary antibodies overnight at 4 °C or for 2 h at room temperature. 
Different primary antibodies were diluted to diverse concentrations in 3% BSA/PBS-T 
as described in Table 4.5. Membranes were washed again three times for 5 min with 
PBS-T and then incubated with secondary antibodies for 1 h at room temperature. 
HRP-coupled secondary antibodies were diluted to diverse concentrations in 3% 
BSA/PBS-T as detailed in Table 4.5. Finally, membranes were washed another three 
times for 5 min with PBS-T. To detect the membrane-bound secondary antibodies, 
membranes were briefly incubated with SuperSignal West Pico enhanced 
chemiluminescence (ECL) substrate (Thermo Scientific) or ECL Prime Western Blotting 
detection reagent (Amersham). Both solutions were prepared freshly according to the 
manufacturer’s instructions. The light signals were detected on SUPER RX films 
(Fujifilm) and films were developed in a Cawomat 2000 IR (Cawo) developing machine. 
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Films were digitalized with an Epson Perfection V800 Photo film scanner (Epson). 
Digital images were quantified using either Bio1D analysis software (Vilber Lourmat) or 
TotalLabQuant (Cleaver Scientific). 
Some of the membranes were stained with fluorophore-conjugated secondary 
antibodies. Importantly, in this case all washing steps were done with PBS instead of 
PBS-T. Moreover, blocking buffer and antibody dilutions were prepared with PBS and 
not PBS-T. The fluorescence signal was detected with the Odyssey CLx Imaging 
system (Li-Cor). 
 
Table 4.5: Primary and secondary antibodies used for Western blotting. 
Antigen Species Dilution Source 
α-tubulin mouse 1:8000 Sigma-Aldrich, T5168 
CDC25A mouse 1:500 Thermo Scientific, Ab-1, Clone DCS-120 
DDB2 mouse 1:200 Abcam, ab51017 
GAPDH mouse 1:20000 Sigma-Aldrich, G8795 
HA rabbit 1:1000 Sigma-Aldrich, H6908 
IκBα mouse 1:1000 Cell Signaling, 4814 
Npl4 rabbit 1:500 H. Meyer, HME18, purified 
p97 rabbit 1:2000 H. Meyer, HME8, serum 
PSMB5 rabbit  1:1000 Abcam, ab3330 
UBXD1 rabbit 1:10000 H. Meyer, E43, serum 
UBXD7 sheep 1 µg/ml G. Alexandru, S409D, serum 
UBXD8 rabbit 1:1000 Novus Biologicals, NBP2-16381 
Ufd1 mouse 1:500 C. Brasseur, 5E2, purified 
HRP-anti mouse goat 1:10000-1:20000 BioRad, 170-6516 
HRP-anti rabbit goat 1:10000-1:20000 BioRad, 170-6515 
HRP-anti sheep rabbit 1:10000-1:20000 Pierce, 31480 
IRDye 800CW  
anti mouse 
donkey 1:2500-1:20000 Li-Cor, 925-32212 
IRDye 800CW  
anti rabbit 
donkey 1:10000-1:15000 Li-Cor, 925-32213 
IRDye800 
anti goat 
donkey 1:5000 Rockland antibodies, 605-732-125 
 
 
4.5 Fluorescence microscopy 
To visualize mitotic defects of mitotic or pre-mitotic origin, kinetochores were stained by 
immunofluorescence using a mixture of primary antibodies binding to kinetochores 
(CREST) and a fluorophore-conjugated secondary antibody. HeLa cells were seeded 
on sterile glass cover slips (0.18 mm in diameter, VWR) in 12-well plates. After siRNA 
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transfection for 48 h and further treatment with DMSO or 0.2 µM APH for 24 h, the cells 
were washed with PBS before fixation with 4% formaldehyde (PFA; Sigma-Aldrich) in 
PBS for 10 min. Following three washing steps with PBS for 5 min each, the cells were 
permeabilized with 0.1% Triton X-100 in PBS for 10 min. The cells were washed again 
three times with PBS for 5 min each and then blocked with 3% BSA (Applichem) in 
PBS for 30 min. After blocking, the cover slips were transferred into a wet chamber, 
where they were placed with the cell side down on drops of primary antibody on 
Parafilm (Bemis) and incubated for 90 min. The primary anti-centromere antibody 
(CREST, human, Antibody Inc., 15-234) was diluted 1:500 in 3% BSA in PBS. 
Following another three washing steps with PBS for 5 min each in 12-well plates, the 
cells were incubated with the secondary Alexa GAH594 antibody (Invitrogen) diluted 
1:500 in 3% BSA in PBS in the wet chamber for 30 min. Then, the cells were washed 
for three times with PBS for 5 min each and washed once with ddH2O to remove 
residual salts. After that, the cover slips were mounted on microscopy slides 
(Marienfeld) with the cell side down on drops of Mowiol (Calbiochem) solution, 
containing 0.5 µg/ml of the DNA dye DAPI. The microscopy slides were dried at room 
temperature and stored at 4 °C. 
The counting of mitotic defects was performed on an inverted fluorescence microscope 
(Axio Observer Z1, Zeiss) using an x63, 1.4 NA objective. Images were taken with an 
inverted spinning-disc confocal microscope (Nikon Eclipse Ti equipped with a 
Yokogawa CSU X-1 spinning disk unit) using an x100, 1.49 NA objective. Images were 
acquired with an Andor iXon X3 EMCCD (electron multiplying charge coupled device) 
camera. 
 
U2OS-FRT-TO cells inducibly expressing GFP-CDC25A were seeded on glass cover 
slips for fluorescence microscopy. One day later, they were induced with 1 µg/ml 
doxycycline for 24 h. After that, they were washed with PBS and fixed with 4% PFA for 
10 min. Then, the cells were washed three times with PBS for 5 min each and 
permeabilized with 0.1% Triton X-100 in PBS for 10 min. Following three washing steps 
with PBS for 5 min each and a brief washing step with ddH2O, the cover slips were 
mounted on microscopy slides with the cell side down on drops of Mowiol solution, 
containing 0.5 µg/ml DAPI. Again, the microscopy slides were dried at room 
temperature and stored at 4 °C. 
Imaging was carried out with an inverted spinning-disc confocal microscope (Nikon 
Eclipse Ti equipped with a Yokogawa CSU X-1 spinning disk unit) using an x40, 0.94 
NA objective. Images were acquired with an Andor iXon X3 EMCCD (electron 
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multiplying charge coupled device) camera. GFP intensity was quantified with 
CellProfiler software (Broad Institute). 
 
4.6 Statistical analysis 
Statistical analyses were performed in SigmaPlot software (Systat). Data were 
analyzed by unpaired, one-tailed Student’s t-test or Mann-Whitney Rank sum test, 
depending on normality and equality of variances. Values of p < 0.05 (*), p < 0.01 (**), 
and p < 0.001 (***) were considered statistically significant. 
 
4.7 Buffers and solutions 
 
TAE buffer  
40 mM Tris 
20 mM acetic acid 
1 mM EDTA 
pH 8.3 
 
SOC medium 
0.5% yeast extract 
2% tryptone 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
10 mM MgSO4 
20 mM glucose 
pH7.0 
 
LB medium 
10 g/l peptone (Fluka) 
10 g/l NaCl 
5 g/l yeast extract (Applichem) 
pH 7.0 
for LB agar plates: 
additional 20 g/l agar (Applichem) 
 
 
 
PBS 
10 mM Na2HPO4 
2.17 mM NaH2PO4 
154 mM NaCl 
pH 7.4 
 
Pepsin/HCl 
5 g/l Pepsin 
55 mM HCl 
 
Extraction buffer 
150 mM KCl 
25 mM Tris, pH 7.4 
5 mM MgCl2 
5% glycerol 
1% Triton X-100 
2 mM β-mercaptoethanol 
pH 7.4 
 
6x SDS loading buffer 
0.35 M Tris, pH 6.8 
30% glycerol  
10% SDS 
9.3% DTT 
0.02% bromophenol blue 
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SDS running buffer 
190 mM glycine 
25 mM Tris 
0. 1% SDS 
pH 8.8 
 
Blotting buffer 
20% methanol 
in SDS running buffer 
 
Wet blot transfer buffer 
0.192 mM glycine 
20.5 mM Tris 
0.04% SDS 
pH 8.3 
20% methanol 
 
Ponceau-S 
2 g/l Ponceau powder 
0.05% acetic acid 
 
PBS-T 
0.05% Tween 20 
in PBS 
pH 7.4 
 
Stripping buffer 
7 M guanidinium chloride 
50 mM glycine 
pH 10.8 
0.5 M EDTA 
0.1 M KCl 
20 mM β-mercaptoethanol 
 
Mowiol 
5 g Mowiol  
20 ml PBS 
stir overnight 
add 10 ml glycerol (87%) 
centrifuge 15 min at 17000 x g 
add 0.5 μg/ml DAPI 
 
PEI (10 mM stock) 
45 mg PEI 
8 ml H2O 
stir at 70 °C for 1h 
pH 7.0 
ad 10 ml dH2O 
steril filter 
dilute 1:10 with dH2O 
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